{
  "medicines": [
    {
      "class": "n/a",
      "type": "n/a",
      "genericName": "Levobunolol",
      "brandName": "Betagan, others",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "n/a",
      "type": "n/a",
      "genericName": "Proparacaine",
      "brandName": "Alcaine, Ophthetic, Ophthaine, others",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "n/a",
      "type": "n/a",
      "genericName": "Timolol",
      "brandName": "Combigan, Timolide, Cosopt",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Anesthetics",
      "type": "GENERAL",
      "genericName": "Desflurane",
      "brandName": "Suprane",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "ANESTHETICS",
      "type": "GENERAL",
      "genericName": "Etomidate",
      "brandName": "Amidate",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in animals Br J Anaesth 1985;57:420. Unsafe in animals"
    },
    {
      "class": "ANESTHETICS",
      "type": "GENERAL",
      "genericName": "Isoflurane",
      "brandName": "Forane",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in animals"
    },
    {
      "class": "ANESTHETICS",
      "type": "GENERAL",
      "genericName": "Ketamine",
      "brandName": "Ketalar",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably safe Br J Anaesth 1985;57:420. Safe in animals"
    },
    {
      "class": "Anesthetics",
      "type": "GENERAL",
      "genericName": "Midazolam",
      "brandName": "Versed",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Cell culture - Safe Substrate of CYP3A4. Transactivates pregnane X receptor, but low probability of CYP3A4 induction (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; Curr Drug Metab 9:827,2008)"
    },
    {
      "class": "ANESTHETICS",
      "type": "GENERAL",
      "genericName": "Propofol",
      "brandName": "Diprivan",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Anaesthesia 1992;47:355 Safe Anaesthesia 1988;43:1022. Safe in patients"
    },
    {
      "class": "ANESTHETICS",
      "type": "GENERAL",
      "genericName": "Sevoflurane",
      "brandName": "Ultane",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution Pediat Anesthes 2005;15:426. Safe USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Only 5% is metabolized, primarily by CYP2E1 (not CYP3A or 2C9)"
    },
    {
      "class": "Anesthetics",
      "type": "General",
      "genericName": "Thiamylal",
      "brandName": "Surital",
      "conclusion": "BAD!",
      "references": "Barbiturate drug"
    },
    {
      "class": "Anesthetics",
      "type": "GENERAL",
      "genericName": "Thiopental",
      "brandName": "Pentothal",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid See Phenobarbital"
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Benzocaine",
      "brandName": "Many",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Bupivacaine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Chloroprocaine",
      "brandName": "Nesacaine",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Dibucaine",
      "brandName": "Nupercainal",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Ethyl chloride",
      "brandName": "Ethyl Chloride",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Prilocaine",
      "brandName": "Citanest",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Unsafe in patients Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Procaine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Ropivacaine",
      "brandName": "Naropin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Substrate of CYP 1A. Use with care in doses >2 mL (of 10 mg/mL solution) Clin Pharmacol Ther 1998;64:484. Mostly metabolized by CYP1A2"
    },
    {
      "class": "ANESTHETICS",
      "type": "LOCAL",
      "genericName": "Tetracaine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals"
    },
    {
      "class": "Anesthetics",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Baclofen",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic http://www.bio.net/bionet/hypermail/neur-sci/2005-July/060879.html: Ca. 85% is excreted unchanged, and ca. 15% of the dose is metabolized primarily by deamination"
    },
    {
      "class": "Anesthetics",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Cyclobenzaprine",
      "brandName": "Flexeril",
      "conclusion": "BAD?",
      "references": "www.drugs.com: Metabolized by CYP3A4; forms ligand with PXR Williams DA. Drug metabolism. In: Foye?s Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANESTHETICS",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Doxacurium",
      "brandName": "Nuromax",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANESTHETICS",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Pancuronium",
      "brandName": "Pavulon",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe"
    },
    {
      "class": "ANESTHETICS",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Succinylcholine",
      "brandName": "Anectine",
      "conclusion": "OK?",
      "references": "Patient report: Safe"
    },
    {
      "class": "ANESTHETICS",
      "type": "MUSCLE RELAXANTS",
      "genericName": "Vecuronium",
      "brandName": "Norcuron",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "AMINOGLYCOSIDES",
      "genericName": "Amikacin",
      "brandName": "Amikin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use PV Tishler MD clinical data: Safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "AMINOGLYCOSIDES",
      "genericName": "Gentamicin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients and animals"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "AMINOGLYCOSIDES",
      "genericName": "Neomycin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "AMINOGLYCOSIDES",
      "genericName": "Streptomycin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe www.porphyriafoundation.com: Safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "AMINOGLYCOSIDES",
      "genericName": "Tobramycin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use S Afr Med J 1984;65:924. Safe in patients"
    },
    {
      "class": "Anti-infectives",
      "type": "Animycobacterial agents",
      "genericName": "Rifapentine",
      "brandName": "Priftin",
      "conclusion": "BAD!",
      "references": "Induces CyP3A, 2C9, ALA synthase (analogous to rifampicin)"
    },
    {
      "class": "Anti-infectives",
      "type": "anthelmintics",
      "genericName": "albendazole",
      "brandName": "multiple",
      "conclusion": "BAD?",
      "references": "poorly absorbed from GI tract; but signif metabolsim by CyP3A4. Poor data.(Eur. J. Clin Pharm 71:528, 2011)"
    },
    {
      "class": "Anti-infectives",
      "type": "anthelmintics",
      "genericName": "mebendazole",
      "brandName": "multiple",
      "conclusion": "No info",
      "references": "Poorly absorbed from GI tract. Probably metabolised by P450."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIFUNGALS",
      "genericName": "Amphotericin B",
      "brandName": "Amphotec",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic/Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIFUNGALS",
      "genericName": "Carbamide Peroxide",
      "brandName": "Debrox",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIFUNGALS",
      "genericName": "Caspofungin",
      "brandName": "Cancidas",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: Metabolized by hydrolysis and N-acetylation"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Clotrimazole",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not /Possibly Porphyrinogenic Comp Biochem Physiol C Toxicol Pharmacol 2005;140:403. Induces CYP3A. Did not affect expression of PXR and MDR1 in zebrafish. Inhibits constituitive androstene receptor."
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Fluconazole",
      "brandName": "Diflucan",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Inhibits Cyt3A,2C9, and pregnane X receptor. 3 Patient reports: Unsafe."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIFUNGALS",
      "genericName": "Flucytosine",
      "brandName": "Ancobon",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture www.porphyriafoundation.com: Safe"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Griseofulvin",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe. Induces CYP3A"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Itraconazole",
      "brandName": "Sporanox",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. substrate & inhibitor of CYP3A4"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Ketoconazole",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in cell culture Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate & inhibitor of CYP3A4. Inhibitor of pregnane X receptor & constit. androstene receptor."
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Metronidazole",
      "brandName": "Flagyl",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: probably safe J Neurol Neurosurg Psychiat 1997;62:421. Sinz: Cur Drug Metab 2006; 7:375: no human pregnane X receptor activation. Unsafe in patients. 1 patient: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Micafungin",
      "brandName": "Mycamine",
      "conclusion": "OK?",
      "references": "Metab by and weakely inhibits CYP3A. 3A is not major path."
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Miconazole",
      "brandName": "Monistat, others",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic/Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in cell culture"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Nystatin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): No P450 metabolism"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIFUNGALS",
      "genericName": "Posaconazole",
      "brandName": "Noxafil",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Terbinafine",
      "brandName": "Lamisil",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Oral -Probably Porphyrinogenic. Topical - ok. web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Vickers, Drug Metab Disp 1999; 27:1029: Main metab via CYP2C9, 1A2, 3A4. Sinz M. Cur Drug Metab 2006; 7:375: High activation of pregnane X receptor but low prediction of clinical induction. (This is given over a ca. 3 month period, so acute experimental data may not be relevant.)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Terconazole",
      "brandName": "Terazol",
      "conclusion": "No info",
      "references": "Induces pregnane X receptor."
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIFUNGALS",
      "genericName": "Voriconazole",
      "brandName": "Vfend",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of & inhibits CYP3A4 & 2C9."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMALARIALS",
      "genericName": "Atovaquone",
      "brandName": "Mepron",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe http://www.pharmgkb.org/: Not much is metabolized"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIMALARIALS",
      "genericName": "Chloroquine",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic, Compare the 8-aminoquioline primaquine: Inducer of CYPs 1A1, 1A2 and 1B1. No data pointing to clinically significant CYP-inducing properties. Conflicting references. One report of possible porphyrinogenicity. www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMALARIALS",
      "genericName": "Hydroxychloroquine",
      "brandName": "Plaquenil",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Partly CYP-metabolized. Compare the 8-aminoquinoline primaquine: Inducer of CYPs 1A1, 1A2 and 1B1"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMALARIALS",
      "genericName": "Mefloquine",
      "brandName": "Lariam",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Substrate for CYP 3A4. No clinical observations pointing to CYP-induction. Compare the other methanolquinoline quinine: Inducer of CYPs 1A1, 1A2 and 2C9. Activator/stimulator of CYP 3A4. Inhibitor of CYPs e.g. 1A1 (potent)."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMALARIALS",
      "genericName": "Primaquine",
      "brandName": "Primaquine",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIMALARIALS",
      "genericName": "Proguanil",
      "brandName": "Malarone (also contains atovaquone)",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic, substrate of CYP2C19, 1A2, 3A4; no clinical observations pointing to CYP induction web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMALARIALS",
      "genericName": "Pyrimethamine",
      "brandName": "Daraprim",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIMALARIALS",
      "genericName": "Quinine Sulfate",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Metab. by CYP3A. Inducer of 2C9. Possible activator/stimulator of CYP 3A4. 1Aweb.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients S Afr Med J 1988;74:321. Safe in patients Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMYCOBACTERIAL AGENTS",
      "genericName": "Ethambutol",
      "brandName": "Myambutol",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMYCOBACTERIAL AGENTS",
      "genericName": "Isoniazid",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Inhibitor of CYP 1A2, 2A6, 2C19, 3A4. Several references warn against its use web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably unsafe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIMYCOBACTERIAL AGENTS",
      "genericName": "Pyrazinamide",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: unsafe in patients www.porphyriafoundation.com: Unsafe"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIMYCOBACTERIAL AGENTS",
      "genericName": "Rifabutin",
      "brandName": "Mycobutin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Substrate of CYP3A4. Induces CYP3A4 via pregnane X receptor transactivation (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch Toxicol 82:667,2008; Cur Drug Metab 7:375,2006)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIMYCOBACTERIAL AGENTS",
      "genericName": "Rifampin",
      "brandName": "Rifadin",
      "conclusion": "BAD!",
      "references": "Substrate of CYP3A4. Induces CYP3A4 via transactivation of pregnane X receptor (Cur Drug Metab 7:375,2006; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIPARASITICS",
      "genericName": "Albendazole",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Caution Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIPARASITICS",
      "genericName": "Iodoquinol",
      "brandName": "Yodoxin",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIPARASITICS",
      "genericName": "Ivermectin",
      "brandName": "Stromectol",
      "conclusion": "BAD?",
      "references": "Xenabiotica 1998; 28: 313. Metabolized extensively by CYP3A4"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIPARASITICS",
      "genericName": "Mebendazole",
      "brandName": "Vermox",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIPARASITICS",
      "genericName": "Praziquantel",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIPARASITICS",
      "genericName": "Tinidazole",
      "brandName": "Tindamax",
      "conclusion": "BAD?",
      "references": "~75% metab by CYP3A4. Porphyrinogenic in vitro (Eur J Clin Pharmacol 59:429,2003)"
    },
    {
      "class": "Anti-infectives",
      "type": "antiretroviral",
      "genericName": "Telbivudine",
      "brandName": "Tyzeka",
      "conclusion": "OK?",
      "references": "Not metabolized; no P450 interaction (Medical Letter 49:11, 2007; Micromedex"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Abacavir",
      "brandName": "Ziagen",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): No P450 metabolism"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Amprenavir",
      "brandName": "Agenerase",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Substrate of CYP3A4. Induces CYP3A4 via transactivation of pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Atazanavir",
      "brandName": "Reyataz",
      "conclusion": "BAD?",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Extensively metabolized by CYP3A4 Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Delavirdine",
      "brandName": "Rescriptor",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Didanosine",
      "brandName": "Videx",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Efavirenz",
      "brandName": "Sustiva",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Metab mainly by CYP2B6, with minor role for CYP3A4. Induces CYP2B6,3A4 via transactivation of constitutive androstane rerceptor & pregnane X receptor (Pharmacogenet Genomics 19:300, 2009; Arch Toxicol 82:667,2008; J Pharmacol Exp Therap 320:72,2007; Clin. Pharmacol. Ther. 91: 475, 2012)."
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Emtricitabine",
      "brandName": "Emtriva, Truvada",
      "conclusion": "OK?",
      "references": "Blum MR: C Clin Pharm 2007; 47:751 - Primarily eliminated via renal excretion; 60-70% recovered unchanged."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Enfuvirtide",
      "brandName": "Fuzeon",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Indinavir",
      "brandName": "Crixivan",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate,inducer and inhibitor of CYP3A4; pregnane X receptor inducer"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Lamivudine",
      "brandName": "Epivir",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.drugs.com: 70% excreted as unchanged drug in urine"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Lopinavir/Ritonavir",
      "brandName": "Kaletra",
      "conclusion": "BAD!",
      "references": "Lopinavir www.drugs-porphyria.org: Probably Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Metabolized mainly by CYP3A, but metabolized by CYP2D6 if used with ritonavir. Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4 Ritonavir www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Substrate of & inhibits CYP3A via human pregnane X receptor transactivation (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T CYP2C9, pregnane X receptor Combination: Induces CYP2C9"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Maraviroc",
      "brandName": "Selzentry",
      "conclusion": "OK?",
      "references": "~50% meetab but does not induce CYP3A4 (Brit J Clin Pharmacol 65S:5,2008; and 66:498,2008)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Nelfinavir",
      "brandName": "Viracept",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Williams DA: Op. Cit.: Substrate & inducer of CYP3A4, 2C9"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Nevirapine",
      "brandName": "Viramune",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. >80% metab, by CYP3A4; also metab by CYP2B6. Induces CYP3A4 & 2B6 via transactivation of constitutive androstane receptor (Arch Toxicol 82:667,2008; Drug Metab Disp 8:895,1999; J Pharmacol Exp Therap 320:72,2007)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Nilotinib",
      "brandName": "Tasigna",
      "conclusion": "No info",
      "references": "~30% metab by CYP3A4 (Clin Therapeutics 30:1956,2008)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Raltegravir",
      "brandName": "Isentress",
      "conclusion": "OK?",
      "references": "No CYP meetabolism or induction (Drug Metab Disp 35:1657,2007)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Ritonavir",
      "brandName": "Norvir",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic. web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Substrate of, induces and inhibits CYP3A via human pregnane X receptor transactivation(Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cur Drug Metab 7:375,2006; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Saquinavir",
      "brandName": "Fortovase",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. CYP 3A4-metabolized. Inhibitor of CYP 3A4, seemingly not potent. Williams DA. Drug metabolism. In: Foye?s Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Stavudine",
      "brandName": "Zerit",
      "conclusion": "NO INFO",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Furanosyl pyrimidine derivative. No P450 metabolism"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "Tenofovir",
      "brandName": "Viread, Truvada",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed: 70-80% eliminated as unchanged drug http://redpoll.pharmacy.ualberta.ca/drugbank/: Not substrate of CYP3A4 or CYP2C9"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Zalcitabine",
      "brandName": "Hivid",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIRETROVIRALS",
      "genericName": "Zidovudine",
      "brandName": "Retrovir",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Acyclovir",
      "brandName": "Acyclovir",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe www.uq.edu.au/porphyria/: Safe in cell culture Patient report: Safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Adefovir",
      "brandName": "Hepsera",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Not a P450 substrate"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Amantidine",
      "brandName": "Many",
      "conclusion": "NO INFO",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed: not metabolized www.rxlist.com: Primarily secreted as unchanged drug"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Famciclovir",
      "brandName": "Famvir",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Ganciclovir",
      "brandName": "Cytovene",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Interferon alfa-2B/Ribavirin",
      "brandName": "Rebetron",
      "conclusion": "OK!",
      "references": "???"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIVIRALS",
      "genericName": "Oseltamivir",
      "brandName": "Tamiflu",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic Not a P450 substrate (USP DI? Drug Info. for the Health Care Pro. - 26th Ed; http://redpoll.pharmacy.ualberta.ca/drugbank/) patient report: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIVIRALS",
      "genericName": "Ribavirin",
      "brandName": "Pegetron (also contains peginterferon)",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed: not p450 substrate www.rxlist.com: Two pathways of metabolism: (i) reversible phosphorylation in nucleated cells; (ii) degradation via deribosylation and amide hydrolysis to yield a triazole carboxylic acid. Should not involve CYP3A4 or CYP2C9"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIVIRALS",
      "genericName": "Valacyclovir",
      "brandName": "Valtrex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use patient report: safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "ANTIVIRALS",
      "genericName": "Zanamivir",
      "brandName": "Relenza",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Not metabolized"
    },
    {
      "class": "Anti-infectives",
      "type": "CEPHALOSPORIN",
      "genericName": "Ceftaroline Fosamil",
      "brandName": "Teflaro",
      "conclusion": "No info",
      "references": "Incomplete information re metabolism (Drugs 69:809, 2009)"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefaclor",
      "brandName": "Ceclor",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefazolin",
      "brandName": "Ancef",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefepime",
      "brandName": "Maxipime",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Anti-infectives",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefotaxime",
      "brandName": "Claforan",
      "conclusion": "OK?",
      "references": "Probably not metab by CYP"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefotetan",
      "brandName": "Cefotan",
      "conclusion": "OK!",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Not metabolized by P450"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefoxitin",
      "brandName": "Mefoxin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Anti-infectives",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefpodoxime Proxetil",
      "brandName": "Vantin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution. Patient report: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "CEPHALOSPORINS",
      "genericName": "Ceftazidime",
      "brandName": "Fortaz",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution. Patient report: safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Ceftriaxone",
      "brandName": "Rocephin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cefuroxime",
      "brandName": "Zinacef",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CEPHALOSPORINS",
      "genericName": "Cephalexin",
      "brandName": "Keflex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution Patient reports: Safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CMV AGENTS",
      "genericName": "Cidofovir",
      "brandName": "Vistide",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CMV AGENTS",
      "genericName": "Fosamprenavir",
      "brandName": "Lexiva",
      "conclusion": "BAD?",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CMV AGENTS",
      "genericName": "Foscarnet",
      "brandName": "Foscavir",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): No P450 metabolism"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "CMV AGENTS",
      "genericName": "Valganciclovir",
      "brandName": "Valcyte",
      "conclusion": "OK!",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Undergoes hydrolysis"
    },
    {
      "class": "Anti-infectives",
      "type": "FLUOROQUINOLONES",
      "genericName": "Ciprofloxacin",
      "brandName": "Cipro",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Safe in Patients PV Tishler MD clinical data & patient reports: Safe J Appl Toxicol 2005;25:339. Inhibits CYP3A"
    },
    {
      "class": "Anti-infectives",
      "type": "FLUOROQUINOLONES",
      "genericName": "Levofloxacin",
      "brandName": "Levaquin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic PV Tishler MD clinical data & patient report: Safe Drug Metab Disp 1996;24:1134. Undergoes limited metabolism http://biocomp.health.unm.edu/ p450/metabP450diseasep3.pdf: Substrate of CYP1 family"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "FLUOROQUINOLONES",
      "genericName": "Moxifloxacin",
      "brandName": "Avelox",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Anti-infectives",
      "type": "FLUOROQUINOLONES",
      "genericName": "Norfloxacin",
      "brandName": "Noroxin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Safe in cell culture J Appl Toxicol 2005;25:339. Inhibits CYP3A"
    },
    {
      "class": "Anti-infectives",
      "type": "MACROLIDES",
      "genericName": "Azithromycin",
      "brandName": "Zithromax",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe. 2 patient reports: safe web.uct.ac.za/depts/porphyria/: Use with Extreme Caution USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Metabolized in liver, but 50% in bile unchanged & 35% metabolized by demethylation Patient reports: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "MACROLIDES",
      "genericName": "Clarithromycin",
      "brandName": "Biaxin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Inhibitor of CYP3A4 but forms irreversible complexes less readily than erythromycin. Some clinical experience of non-porphyrinogenicity. Two references state non- porphyrinogenicity. web.uct.ac.za/depts/porphyria/: Use with Caution www.uspharmacist.com: Inhibitor of CYP3A4 Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007: Substrate & inhibitor of CYP3A4 Sinz: Cur Drug Metab 2006; 7:375: no human pregnane X receptor activation"
    },
    {
      "class": "Anti-infectives",
      "type": "MACROLIDES",
      "genericName": "Erythromycin",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007: Substrate of, induces & inhibits CYP3A4. Patient report: Unsafe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Aztreonam",
      "brandName": "Azactam",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Metabolized via hydrolysis"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Bacitracin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Chloramphenicol",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP2C9"
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Clindamycin",
      "brandName": "Cleocin",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of & induces CYP3A4 Patient report: Safe"
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Dapsone",
      "brandName": "Leprostatic",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4 & CYP2C9"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Daptomycin",
      "brandName": "Cubicin",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Fosfomycin",
      "brandName": "Monurol",
      "conclusion": "OK?",
      "references": "Mainly not metabolized (Ann Pharmacother 32:215,1998) patient report: safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Linezolid",
      "brandName": "Zyvox",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic; insufficient data on metabolism but no indications for P450 interaction in vivo. USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Not metabolized by P450"
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Meropenem",
      "brandName": "Meronem",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: 70% excreted as unchanged drug"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Mupirocin",
      "brandName": "Bactroban",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Probably not significantly absorbed. Probably not metabolized by P450"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Polymyxin B",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "MISCELLANEOUS",
      "genericName": "Tigecycline",
      "brandName": "Tygacil",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "MISCELLANEOUS",
      "genericName": "Vancomycin",
      "brandName": "Vancocin, Others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Br J Clin Pharmacol 1990;29:273. Safe"
    },
    {
      "class": "Anti-infectives",
      "type": "PENEM ANTIBIOTICS",
      "genericName": "Doripenem",
      "brandName": "Doribax",
      "conclusion": "OK!",
      "references": "Not a CYP substrate (Clin Therapeut 31:42,2009)"
    },
    {
      "class": "Anti-infectives",
      "type": "PENEM ANTIBIOTICS",
      "genericName": "Ertapenem",
      "brandName": "Invanz",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: Does not appear to undergo hepatic metabolism"
    },
    {
      "class": "Anti-infectives",
      "type": "PENEM ANTIBIOTICS",
      "genericName": "Imipenem/Cilastatin",
      "brandName": "Primaxin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Not metabolized by P450"
    },
    {
      "class": "Anti-infectives",
      "type": "PENICILLINS",
      "genericName": "Amoxicillin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data & patient reports: Safe Pregnane X receptor inducer."
    },
    {
      "class": "Anti-infectives",
      "type": "PENICILLINS",
      "genericName": "Amoxicillin/ Clavulanate",
      "brandName": "Augmentin",
      "conclusion": "OK!",
      "references": "patient report: safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Ampicillin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Ampicillin/Sulbactam",
      "brandName": "Unasyn",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Carbenicillin",
      "brandName": "Geopen",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Anti-infectives",
      "type": "PENICILLINS",
      "genericName": "Dicloxacillin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic. Induces CYP3A."
    },
    {
      "class": "Anti-infectives",
      "type": "Penicillins",
      "genericName": "flucloxacillin",
      "brandName": "Floxapen, etc.",
      "conclusion": "BAD?",
      "references": "Not metabolizd by or inhibits CYP3A, 2C9, but induces CYP3A, PXR"
    },
    {
      "class": "Anti-infectives",
      "type": "PENICILLINS",
      "genericName": "Nafcillin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "http://medicine.iupui.edu/flockhart/table.htm: CYP3A inducer."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Oxacillin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "http://www.rxlist.com/cgi/generic3/oxacillin_cp.htm: Rapidly excreted as unchanged drug"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Penicillin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Patient report: Safe"
    },
    {
      "class": "Anti-infectives",
      "type": "PENICILLINS",
      "genericName": "Piperacillin",
      "brandName": "Zosyn, etc.",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use. Patient report: safe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "PENICILLINS",
      "genericName": "Ticarcillin",
      "brandName": "Ticar",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "SEPSIS SYNDROME AGENTS - NON-ANTIBIOTIC",
      "genericName": "Drotrecogin alfa",
      "brandName": "Xigris",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "SULFONAMIDES",
      "genericName": "Sulfadiazine",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Medicine (Balt) 1992;71:1. Unsafe"
    },
    {
      "class": "Anti-infectives",
      "type": "SULFONAMIDES",
      "genericName": "Sulfamethoxazole/ Trimethoprim",
      "brandName": "Bactrim",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Medicine (Balt) 1992;71:1. Unsafe. CYP2C9 substrate. Pregnane X receptor inducer."
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "SULFONAMIDES",
      "genericName": "Sulfasalazine",
      "brandName": "Azulfidine",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Medicine (Balt) 1992;71:1. Unsafe"
    },
    {
      "class": "ANTI-INFECTIVES",
      "type": "TETRACYCLINES",
      "genericName": "Demeclocycline",
      "brandName": "Declomycin",
      "conclusion": "NO INFO",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic"
    },
    {
      "class": "Anti-infectives",
      "type": "TETRACYCLINES",
      "genericName": "Doxycycline",
      "brandName": "Vibramycin, others",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic/Probably Not Porphyrinogenic. Induces Pgrenane X receptor. web.uct.ac.za/depts/porphyria/: Avoid 2 patient reports: safe 1 patient report: unsafe"
    },
    {
      "class": "Anti-infectives",
      "type": "TETRACYCLINES",
      "genericName": "Minocycline",
      "brandName": "Dynacin, Minocin",
      "conclusion": "No info",
      "references": "www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "Anti-infectives",
      "type": "TETRACYCLINES",
      "genericName": "Tetracycline",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Induces CYP3A. 1 patient report: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "URINARY ANTI-INFECTIVES",
      "genericName": "Methenamine Mandelate",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use patient report: safe"
    },
    {
      "class": "Anti-infectives",
      "type": "URINARY ANTI-INFECTIVES",
      "genericName": "Nitrofurantoin",
      "brandName": "Macrodantin, Macrobid",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably Unsafe"
    },
    {
      "class": "Antidiabetics",
      "type": "Biguanides",
      "genericName": "Metformin",
      "brandName": "Glucophage, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not porphyrinogenic. www.porphyria-europe.com: Safe. web.uct.ac.za/depts/porphyria/: Use. www.uq.edu/au/porphyria/: Safe in animals. Excreted largely unchanged; no hepatic metab (www.clinicalpharmacology-ip.com). Inhibits pregnane X receptor"
    },
    {
      "class": "Antidiabetics",
      "type": "Dopamine Agonist",
      "genericName": "Bromocriptine",
      "brandName": "Cycloset",
      "conclusion": "BAD!",
      "references": "See Bromocriptine, brand name Parlodel, in Central Nervous System Agents, Antiparkinson agents."
    },
    {
      "class": "Antidiabetics",
      "type": "DPP-4 Inhibitor",
      "genericName": "Linagliptin",
      "brandName": "Tradjenta, Jentadueto",
      "conclusion": "OK?",
      "references": ">75% excreted unchanged. Major meteabolite created via CYP3A4, which is not induced (Drug Metab Disp 2010; 38:667)."
    },
    {
      "class": "Antidiabetics",
      "type": "DPP-4 Inhibitors",
      "genericName": "Saxagliptin",
      "brandName": "Onglyza, Kombiglyze XR",
      "conclusion": "No info",
      "references": "Primarily metab. by CYP3A4/5 (Clin Pharmacokinet 49:573, 2010)"
    },
    {
      "class": "Antidiabetics",
      "type": "DPP-4 Inhibitors",
      "genericName": "Sitagliptin",
      "brandName": "Januvia",
      "conclusion": "OK?",
      "references": "~80% not metab; rest mainly by CYP3A4 (Drug Metab Disp 35:523,2007)"
    },
    {
      "class": "Antidiabetics",
      "type": "DPP-4 Inhibitors/ Biguanides",
      "genericName": "Saxagliptin/ Metformin",
      "brandName": "Kombiglyze XR",
      "conclusion": "No info",
      "references": "See Saxagliptin"
    },
    {
      "class": "Antidiabetics",
      "type": "DPP-4 Inhibitors/ Biguanidess",
      "genericName": "Sitagliptin/ Metformin",
      "brandName": "Janumet",
      "conclusion": "OK?",
      "references": "See Sitagliptin"
    },
    {
      "class": "Antidiabetics",
      "type": "GLP-1 Receptor Agonist",
      "genericName": "Exenatide",
      "brandName": "Byetta",
      "conclusion": "OK?",
      "references": "Drug is a peptide, with peptide metabolism. Physicians' Desk Reference 2010; 64:648"
    },
    {
      "class": "Antidiabetics",
      "type": "GLP-1 Receptor Agonist",
      "genericName": "Liraglutide",
      "brandName": "Victoza",
      "conclusion": "OK?",
      "references": "Polypeptide-fatty acid, metabolized enzymatically. Drug Metab Disp 2010; 38:1944."
    },
    {
      "class": "Antidiabetics",
      "type": "Insulin",
      "genericName": "Insulin detmir",
      "brandName": "Levemir",
      "conclusion": "OK!",
      "references": "Insulin analog; insulins are ok."
    },
    {
      "class": "Antidiabetics",
      "type": "Insulins",
      "genericName": "Insulins",
      "brandName": "Insulin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not porphyrinogenic. www.porphyria-europe.com: Safe. web.uct.ac.za/depts/porphyria/: Use. www.uq.au/porphyria/: Safe in patients"
    },
    {
      "class": "Antidiabetics",
      "type": "Meglitinides",
      "genericName": "Repaglinide",
      "brandName": "Prandin",
      "conclusion": "OK?",
      "references": "Metab mainly by CYP2C8, less by CYP3A4. No evidence of inducing CYPs (Clin Pharmacol Therap 77:341,2005; Med Letter 51:41,2009)"
    },
    {
      "class": "Antidiabetics",
      "type": "Meglitinides/ Biguanides",
      "genericName": "Repaglinide/ Metformin",
      "brandName": "PrandiMet",
      "conclusion": "OK?",
      "references": "See Repaglinide"
    },
    {
      "class": "Antidiabetics",
      "type": "Sulfonylureas",
      "genericName": "Glimepiride",
      "brandName": "Amaryl",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly porphyrinogenic. Substrate of CYP2C9. Significantly transactivates pregnane X receptor but has a low probability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Meetab 7:375,2006)"
    },
    {
      "class": "Antidiabetics",
      "type": "Sulfonylureas",
      "genericName": "Glipizide",
      "brandName": "Glucotrol",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly porphyrinogenic. www.porphyria-europe.com:Safe. web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/ : Unsafe in patients. Metab by CYP2C9(Pharmacogenetics 9:71,1999)"
    },
    {
      "class": "Antidiabetics",
      "type": "Sulfonylureas",
      "genericName": "Glyburide",
      "brandName": "Micronase, Diabeta, others",
      "conclusion": "OK?",
      "references": "Medicine (Balt) 71:1,1992 - Safe. Major metab by CYP2C9, minor metab by CYP3A4. No evidence for CYP induction (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed Lemke T and Williams TA. Baltimore, Williams & Wilkins, 6th ed, 2007; Clin Pharm Therap 85:78,2008)"
    },
    {
      "class": "Antidiabetics",
      "type": "Sulfonylureas/ Biguanides",
      "genericName": "Glipizide/ Metformin",
      "brandName": "Metaglip",
      "conclusion": "BAD?",
      "references": "See Glipizide"
    },
    {
      "class": "Antidiabetics",
      "type": "Sulfonylureas/ Biguanides",
      "genericName": "Glyburide/ Metformin",
      "brandName": "Glucovance",
      "conclusion": "OK?",
      "references": "See Glyburide"
    },
    {
      "class": "Antidiabetics",
      "type": "Thiazolidinediones",
      "genericName": "Pioglitazone",
      "brandName": "Actos",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably porphyrinogenic. USP DI Drug Info. for the Health Care Pro. - 26th ED: Extensively metab by CYP2C8 & 3A4. Induces CYP3A4 & transactivates pregnane X receptor but at concns. higher than usual (Drug Metab Disp 31:439,2003;Curr Drug Metab 7:375,2006; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Drug Metab Dispos 31:439,2003; Mol Pharmavcol 80:518, 2011)"
    },
    {
      "class": "Antidiabetics",
      "type": "Thiazolidinediones",
      "genericName": "Rosiglitazone",
      "brandName": "Avandia",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably porphyrinogenic. Metab by CYP2C9, CYP2C8. Induces CYP3A4 & 2B6, & does transactivate pregnane X receptor (Pharmaceutical Res 23:1089,2006; Eur J Pharm Sci 11:185,2000; Drug Metab Disp 31:439,2003; Curr Drug Metab 7:375,2006) Patient report: Safe"
    },
    {
      "class": "Antidiabetics",
      "type": "Thiazolidinediones/ Biguanides",
      "genericName": "Pioglitazone/ Metformin",
      "brandName": "Actoplus Met",
      "conclusion": "BAD?",
      "references": "See Pioglitazone"
    },
    {
      "class": "Antidiabetics",
      "type": "Thiazolidinediones/ Biguanides",
      "genericName": "Rosiglitazone/ Metformin",
      "brandName": "Avandamet",
      "conclusion": "BAD?",
      "references": "See Rosiglitazone"
    },
    {
      "class": "ANTIDOTES",
      "type": "n/a",
      "genericName": "Deferoxamine",
      "brandName": "Desferal",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.rxlist.com: Mostly metabolized by plasma enzymes"
    },
    {
      "class": "ANTIDOTES",
      "type": "n/a",
      "genericName": "Dimercaprol",
      "brandName": "BAL",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe"
    },
    {
      "class": "ANTIDOTES",
      "type": "n/a",
      "genericName": "Edetate",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "ANTIDOTES",
      "type": "n/a",
      "genericName": "Ipecac",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Antidotes",
      "type": "n/a",
      "genericName": "Physostigmine",
      "brandName": "Antilirium, others",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Antidotes",
      "type": "SMOKING CESSATION",
      "genericName": "Varenicline",
      "brandName": "Chantix",
      "conclusion": "OK?",
      "references": "J Clin Pharmacol 2006; 46:991: not a human P450 substrate; mostly excreted unchanged in animals."
    },
    {
      "class": "Antineoplastics",
      "type": "ALKYLATING AGENTS",
      "genericName": "Carboplatin",
      "brandName": "Paraplatin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution No P450 metabolism. Does not induce CYP3A4 or transactivate pregnane X receptor (USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006); Cancer Chemother Pharmacol 64:35,2009). Publ report: safe (Exp Opin Drug Saf 2008; 7:159)"
    },
    {
      "class": "Antineoplastics",
      "type": "ANTIESTROGENS",
      "genericName": "Tamoxifen",
      "brandName": "Nolvadex",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Safe in patients Metab by CYP3A4,2B6,2C9,2D6. Minimally to modestly transactivates pregnane X receptor; inhibits CYP (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; Clin Therapeutics 30:1385,2008; Cancer Chemother Pharmacol 64:35,2009; Curr Drug Metab 9:598,2008)"
    },
    {
      "class": "Antineoplastics",
      "type": "ANTIMETABOLITES",
      "genericName": "Fluorouracil, 5-Fluorouracil",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution. Safe in patients. Does not induce CYP3A4 or transactivate pregnane X receptor (S Afr Med J 65:924,1984; Cancer Chemother Pharmacol 64:35,2009). Pub rpt: safe (Exp Opin Drug Saf 2008; 7:159). Patient report:as skin cream, safe"
    },
    {
      "class": "Antineoplastics",
      "type": "ANTIMETABOLITES",
      "genericName": "Methotrexate",
      "brandName": "Trexall, Rheumatrex, others",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in animals S Afr Med J 1984;65:924. Safe in patients Xenobiotica 1996;26:503. Limited or no interaction with CYP2C9 and CYP3A4 except for inhibition of Cyp3A. No effect on pregnane X receptor (Curr Drug Metab 7:375,2006; Drug Metab Dispos 32:348,2004)"
    },
    {
      "class": "Antineoplastics",
      "type": "ENZYME INHIBITORS",
      "genericName": "Imatinib",
      "brandName": "Gleevac",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Metab by CYP3A4, less by 2C9; induces and inhibits both. Does not transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics",
      "type": "MISC.",
      "genericName": "Denosumab",
      "brandName": "Xgeva",
      "conclusion": "OK!",
      "references": "Antibody for skeletal mets., osteoporosis."
    },
    {
      "class": "Antineoplastics",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Docetaxel",
      "brandName": "Taxotere, etc.",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Metab mainly by CYP3A4. Does not induce CYP3A, 2C9; weakly inhibits 3A. No to minimal transactivation of human pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Pharmacogenetics 8:391,1998; Cur Drug Metab 7:375,2006; Cancer Chemother Pharmacol 64:35,2009. pt report pupblished: safe (Expert Opin Druf Saf 2008; 7:159. Patient report: safe."
    },
    {
      "class": "Antineoplastics",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Etoposide",
      "brandName": "Eposin, Etopophos, Vepesid",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.uq.edu.au/porphyria/: Safe in patients Extensively metab by & induces CYP3A4. Transactivates pregnane X receptor & induces CYP3A4 in several studies, but not in one study (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Mol Pharmacol 2002;62:439; Clin Therapeutics 30; 1385,2008; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics",
      "type": "Mitotic Inhibitors",
      "genericName": "Gefitinib",
      "brandName": "Iressa",
      "conclusion": "OK?",
      "references": "Well absorbed. Metabolized by CYP3A. Does not induce/inhibit CYP3a, 2C9."
    },
    {
      "class": "Antineoplastics",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Paclitaxel",
      "brandName": "Taxol",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Minor metabolism by,& induces CYP3A4. Transactivates and induces pregnane X receptor (Pharmacogenomics 8:803,2007; Clin Cancer Res 11: 6359,2005; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics",
      "type": "NITROGEN MUSTARDS",
      "genericName": "Cyclophosphamide",
      "brandName": "Cytoxan",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in animals S Afr Med J 1984;65:924. Safe in patients Mainly metab by CYP2B6,~10% by CYP3A4. Minimally/moderately transactivates pregnane X receptor; strong constitutive androstane receptor activator. Does not induce CYP3A4, but does induce CYP2C9, CYP2B6 (Biochem Pharmacol 59:961,2000; Cancer Chemother Pharmacol 64:35,2009; Curr Drug Metab 9:598,2008; J Pharmacol Exp Therap 320:72, 2007) Patient report: Safe"
    },
    {
      "class": "Antineoplastics",
      "type": "TOPOISOMERASE I INHIBITORS",
      "genericName": "Topotecan",
      "brandName": "Hycamtin",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Does induce CYP3A4 and transactivate pregnane X receptor (Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics",
      "type": "TOPOSIOMERASE INHIBITORS",
      "genericName": "irinotecan",
      "brandName": "Camptosar",
      "conclusion": "BAD?",
      "references": "Major metab by & inhibits CYP3A4, also by CYP2B6. Strongly induces both CYPs in some studies, but neither induces CYP3A4 or transactivates pregnane X receptor in another study (Clin Cancer Res 7:2182,2001; Clin Therapeutics 30:1385,2008; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics",
      "type": "TROPOISOMERASE INHIBITORS",
      "genericName": "Doxorubicin",
      "brandName": "Doxil, Adriamycin",
      "conclusion": "OK!",
      "references": "Does not induce CYPs or transactivate pregnane X receptor(Canad J Physiol Pharmacol 77:589,1999; Cancer Chemother Pharmacol 64:35,2009). Publ. report: safe (Exp Opin Drug Saf 2008; 7:159)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ALKYLATING AGENTS",
      "genericName": "Busulfan",
      "brandName": "Myleran",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ALKYLATING AGENTS",
      "genericName": "Cisplatin",
      "brandName": "Platinol, Blastolem, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Does not induce CYP3A4 or trnasactivate pregnane X receptor (Cancer Chemother Pharmacol 64:35,2009)."
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ALKYLATING AGENTS",
      "genericName": "Procarbazine",
      "brandName": "Natulan",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution S Afr Med J 1984;65:924. Safe in patients"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ALKYLATING AGENTS",
      "genericName": "Thiotepa",
      "brandName": "Thioplex",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANGIOGENESIS INHIBITORS",
      "genericName": "Bevacizumab",
      "brandName": "Avastin",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIANDROGENS",
      "genericName": "Flutamide",
      "brandName": "Eulexin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Possibly metabolised by P450. Possibly ALAS-inducer. Metabolized by CYP3A or CYP2C9. Modestly transactivates pregnane X receptor and markedly induces CYP3A4 (J Gastroenterol 2006;41:231; Cancer Chemother Pharmacol 64:35,2009) Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Actinomycin D or Dactinomycin",
      "brandName": "Cosmegen",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.uq.edu.au/porphyria/: Safe in animals"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Bleomycin",
      "brandName": "Blenoxane",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Metabolized by CYP1A1"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Idarubicin",
      "brandName": "Idamycin",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Mitomycin",
      "brandName": "Mutamycin",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Insufficient data on metabolism. Little systemic resorption; probably safe for intravesical installation"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Mitoxantrone",
      "brandName": "Novantrone",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Insufficient data on metabolism Largely unmetabolized. web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBIOTICS",
      "genericName": "Plicamycin",
      "brandName": "Mithracin",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBODIES",
      "genericName": "Alemtuzumab",
      "brandName": "Campath",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Not metabolized"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBODIES",
      "genericName": "Cetuximab",
      "brandName": "Erbitux",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIBODIES",
      "genericName": "Rituximab",
      "brandName": "Rituxan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: No liver metabolism"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIESTROGENS",
      "genericName": "Megestrol",
      "brandName": "Megace",
      "conclusion": "BAD!",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Azacitidine",
      "brandName": "Vidaza",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Capecitabine",
      "brandName": "Xeloda",
      "conclusion": "OK?",
      "references": "Not metab by CYP. Metab to 5-fluorouracil, which does not induce CYPs (Drug Metab Disp 32:762,2004; Canad J Physiol Pharmacol 74:150,1996)"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Capecitabine",
      "brandName": "Xeloda",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Cladribine",
      "brandName": "Leustatin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: Not P450 substrate"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Cytarabine",
      "brandName": "Alexan, Cytarabin, Cytocin, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: Not P450 substrate"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Floxuridine",
      "brandName": "FUDR",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Fludarabine",
      "brandName": "Fludara, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: Not P450 substrate"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Pemetrexed",
      "brandName": "Alimta",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ANTIMETABOLITES",
      "genericName": "Thioguanine",
      "brandName": "Lanvis",
      "conclusion": "OK!",
      "references": "S Afr Med J 1984;65:924. Safe in patients"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "AROMATASE INHIBITORS",
      "genericName": "Letrozole",
      "brandName": "Femara",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Administered in rather low dose. CYP 3A4 and 2A6-mediated metabolism. Not an inhibitor of CYP19. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ENZYME INHIBITORS",
      "genericName": "Erlotinib",
      "brandName": "Tarceva",
      "conclusion": "OK?",
      "references": "Williams DA. ~70% metab by CYP3A4. Modestly transactivates pregnane X receptor but does not induce CYP3A4 (Eur J Clin Pharmacol 64:31,2008; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ENZYME INHIBITORS",
      "genericName": "Lapatinib",
      "brandName": "Tykerb",
      "conclusion": "OK?",
      "references": "Metab mainly by CYP3A4,3A5. No evidence for CYP induction (Drugs 67:2101,2007)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ENZYME INHIBITORS",
      "genericName": "Sorafenib",
      "brandName": "Nexavar",
      "conclusion": "No info",
      "references": "~50% metab by CYP3A4, ~50% not metab (PDR 63:784,2009)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "ENZYME INHIBITORS",
      "genericName": "Sunitinib",
      "brandName": "Sutent",
      "conclusion": "OK?",
      "references": "~30% metab by CYP3A4, ~40% not metab (PDR 63:2540,2009; Medical Letter 49:18,2007). Does not induce CYPs (Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "ENZYMES",
      "genericName": "Asparaginase",
      "brandName": "Elspar",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "HORMONAL AGENTS",
      "genericName": "Diethylstilbestrol",
      "brandName": "Many",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "HORMONAL AGENTS",
      "genericName": "Estramustine",
      "brandName": "Emcyt",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "HORMONAL AGENTS",
      "genericName": "Testolactone",
      "brandName": "Teslac",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "IMMUNOMODULATORS",
      "genericName": "Levamisole",
      "brandName": "Ergamisol",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "INTERLEUKINS",
      "genericName": "Aldesleukin",
      "brandName": "Proleukin",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "KERATINOCYTE GROWTH FACTOR",
      "genericName": "Palifermin",
      "brandName": "Kepivance",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Arsenic Trioxide",
      "brandName": "Trisenox",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Dacarbazine",
      "brandName": "Dtic-Dome",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Not porphyrinogenic in chick embryo model. Like chloroambucil, melphalan, may be safer than other alkylating agents."
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Hydroxyurea",
      "brandName": "Hydrea",
      "conclusion": "OK?",
      "references": "S Afr Med J 1984;65:924. Safe in patients"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Interferon Alfa-2A",
      "brandName": "Roferon-A",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Liver metabolism is minor pathway http://medicine.iupui.edu/flockhart/table.htm: Inhibitor of CYP1A2"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Interferon Alfa-2B",
      "brandName": "Intron A",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution http://medicine.iupui.edu/flockhart/table.htm: Inhibitor of CYP1A2"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Interferon Gamma-1B",
      "brandName": "Actimmune",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution http://medicine.iupui.edu/flockhart/table.htm: Inhibitor of CYP1A2"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Ixabepilone",
      "brandName": "Ixempra",
      "conclusion": "BAD?",
      "references": "Highly metab by and induces CYP3A4; weakly transactivates pregnane X receptor (Clin Cancer Res 14:2701,2008; S Mani, pers commun)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "oxaliplatin",
      "brandName": "Eloxatin",
      "conclusion": "OK?",
      "references": "No evidence for CYP metabolism (PDR 63:2731,2009)"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MISC.",
      "genericName": "Pentostatin",
      "brandName": "Nipent",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Vinblastine",
      "brandName": "Velban",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably safe in cell culture Extensively metab by CYP3A4. Does not induce CYP3A4 or transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Vincristine",
      "brandName": "Oncovin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Porphyrinogenic in vitro. Administered in low weekly dose, probably insignificant hepatic exposure. Some clinical reports of non-porphyrinogenicity. web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably safe in cell culture S Afr Med J 1984;65:924. Safe in patients USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Metabolized by CYP3A4. Does not induce CYP3A4 or transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cancer Chemother Pharmacol 64:35,2009)"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "MITOTIC INHIBITORS",
      "genericName": "Vinorelbine",
      "brandName": "Navelbine",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Substrate for CYP 3A4. No reports of CYP-induction in humans. Other vinca alkaloids have shown to be porphyrinogenic in vitro. Drug Metab Dispos 2000;28:1121. Major interaction with CYP3A4"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROGEN MUSTARDS",
      "genericName": "Chlorambucil",
      "brandName": "Leukeran",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Insufficient data on metabolism. Conflicting references. Considered better tolerated than other alkylating agents generally avoided. One case report of uneventful use in a 54 yr old patient with IAP. web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in animals"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "NITROGEN MUSTARDS",
      "genericName": "Ifosfamide",
      "brandName": "Ifex",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Substrate of CYP3A4. Modestly transactivates pregnane X receptor. Does not induce CYP3A4 but does induce CYP2B6(Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Cancer Chemother Pharmacol 64:35,2009; Curr Drug Mdetab 9:598,2008)"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROGEN MUSTARDS",
      "genericName": "Mechlorethamine",
      "brandName": "Mustargen",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROGEN MUSTARDS",
      "genericName": "Melphalan",
      "brandName": "Alkeran",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Not porphyrinogenic in experimental rat and chicken systems. Two references safe/probably safe. www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably safe"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROSOUREAS",
      "genericName": "Carmustine",
      "brandName": "Bicnu",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROSOUREAS",
      "genericName": "Lomustine",
      "brandName": "Ceenu",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank: CYP3A4 substrate"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "NITROSOUREAS",
      "genericName": "Streptozocin",
      "brandName": "Zanosar",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "RETINOIDS",
      "genericName": "Tretinoin",
      "brandName": "Retin-A",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic Williams DA: Op. Cit.: Substrate of CYP3A4"
    },
    {
      "class": "Antineoplastics (Cancer Therapies)",
      "type": "Thyroid Cancer-Specific",
      "genericName": "Radioactive Iodine (I-131)",
      "brandName": "none",
      "conclusion": "OK!",
      "references": "Patient experience"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "URINARY TRACT PROTECTIVE AGENTS",
      "genericName": "Amifostine",
      "brandName": "Ethyol",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic http://redpoll.pharmacy.ualberta.ca/drugbank/: No P450 metabolism"
    },
    {
      "class": "ANTINEOPLASTICS (Cancer Therapies)",
      "type": "URINARY TRACT PROTECTIVE AGENTS",
      "genericName": "Mesna",
      "brandName": "Mesnex",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Abatacept",
      "brandName": "Orencia",
      "conclusion": "OK!",
      "references": "Protein. Not metab by CYPs (PDR 63:921,2009)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "adalimumab",
      "brandName": "Humira",
      "conclusion": "OK!",
      "references": "Protein. Not metab by CYPs (PDR 63:442,2009)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Celecoxib",
      "brandName": "Celebrex",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly porphyrinogenic. Metab.~80% by CYP2D9, <25% by CYP3A4; transactivates pregnane X receptor & induces CYP3A4 (Clin Pharmacokinetics 42:283, 2003; Durg Metab Disp 33:1567,2005; Clin Pharm Therap 80:298,2006)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Certolizumab Pegol",
      "brandName": "Cimzia",
      "conclusion": "OK!",
      "references": "Protein + polyethylene glycol. Not metab by CYPs (PDR 63:3127,2009)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "etanercept",
      "brandName": "Enbrel",
      "conclusion": "OK!",
      "references": "Protein. Not metab by CYPs (PDR 63:569,2009)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Golimumab",
      "brandName": "Simponi",
      "conclusion": "OK!",
      "references": "Protein. No CYP metabolism"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Leflunomide",
      "brandName": "Arava",
      "conclusion": "No info",
      "references": "Prob metab by CYPs (www.clinicalpharmacology-ip.com)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Allopurinol",
      "brandName": "Zyloprim",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals Patient reports: Safe"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Auranofin",
      "brandName": "Ridaura",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Aurothioglucose",
      "brandName": "Solganal",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Colchicine",
      "brandName": "Colsalide",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Int J Biochem 1985;17:937. Safe in patients Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Gold Sodium Thiomalate",
      "brandName": "Myochrysin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in animals"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Penicillamine",
      "brandName": "Cuprimine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Probenecid",
      "brandName": "Benemid",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably unsafe Little to no induction of CYPs and no transactivation of pregnane X receptor (Curr Drug Metab 7:375,2006; Drug Metab Dispos 32:348,2004)"
    },
    {
      "class": "Arthritis",
      "type": "n/a",
      "genericName": "Sulfinpyrazone",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in cell culture Major metabolism by CYP3A4,2C9. Induces CYP3A4 via transactivation of pregnane X receptor (Drug Metab Disp 29:701,2001; Arch toxicol 82:667,2008; Cur Drug Metab 7:375,2006). Inhibits CYP2C9."
    },
    {
      "class": "Arthritis",
      "type": "Gout Treatment",
      "genericName": "Pegloticase",
      "brandName": "Krystexxa",
      "conclusion": "OK!",
      "references": "Protein enzyme, with no metabolic problem"
    },
    {
      "class": "Blood related",
      "type": "ANTICOAGULANTS",
      "genericName": "Dabigatran",
      "brandName": "Pradaxa",
      "conclusion": "OK!",
      "references": "No appreciable P450 metab. (Drug Metab Disp 36:386, 2008)"
    },
    {
      "class": "Blood related",
      "type": "ANTICOAGULANTS",
      "genericName": "Fondaparinux",
      "brandName": "Arixtra",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed: 77% eliminated unchanged. Patient report: safe"
    },
    {
      "class": "Blood related",
      "type": "Bleeding retardant",
      "genericName": "Tranexamic acid",
      "brandName": "Lystela, etc.",
      "conclusion": "OK!",
      "references": "Mostly excreted unchanged"
    },
    {
      "class": "Blood related",
      "type": "Plasma Replacement",
      "genericName": "Hydroxyethyl starch",
      "brandName": "Voluven",
      "conclusion": "OK!",
      "references": "Not metabolized in any injurious way."
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Abciximab",
      "brandName": "Reopro",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Argatroban",
      "brandName": "Argatroban",
      "conclusion": "OK?",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed: CYP3A4/5 is not an important elimination pathway"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Bivalirudin",
      "brandName": "Angiomax",
      "conclusion": "OK?",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Clearance from plasma does not seem to involve liver"
    },
    {
      "class": "Blood related therapy",
      "type": "ANTICOAGULANTS",
      "genericName": "Clopidogrel",
      "brandName": "Plavix",
      "conclusion": "OK?",
      "references": "Metab by a number of CYPs. CYP3A4 and 2C19 are probably the most important, but their relative contributions are unknown. Does not induce CYP3A4 (Drug Metab Pharmacokinet 23:412,2008; Drug Metab Rev 37:99,2005; WC Lau, Pers Commun; MP Knadler, Pers Commun)"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Dalteparin",
      "brandName": "Fragmin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Dipyridamole",
      "brandName": "Persantine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Enoxaparin",
      "brandName": "Lovenox",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Blood related therapy",
      "type": "ANTICOAGULANTS",
      "genericName": "Eptifibatide",
      "brandName": "Integrilin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic Clin Ther 1998;20:307. Polypeptide; deamidation probably via hydrolysis, not inlving P450"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Heparin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Blood related therapy",
      "type": "ANTICOAGULANTS",
      "genericName": "Lepirudin",
      "brandName": "Refludan",
      "conclusion": "OK!",
      "references": "Polypeptide. Not metab by CYPs"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Protamine",
      "brandName": "Protamine",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Blood related therapy",
      "type": "ANTICOAGULANTS",
      "genericName": "Ticlopidine",
      "brandName": "Ticlid",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic http://medicine.iupui.edu/flockhart/table.htm: Similar to (and see discussion of) clopidogrel"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "ANTICOAGULANTS",
      "genericName": "Warfarin",
      "brandName": "Coumadin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Williams DA. Drug metabolism. In: Foye?s Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4 & 2C9"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "HEMATOPOIETICS",
      "genericName": "Cyanocobalamin",
      "brandName": "Vitamin B12",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic PV Tishler, MD clinical data: Safe"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "HEMATOPOIETICS",
      "genericName": "Epoetin Alfa",
      "brandName": "Epogen",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe"
    },
    {
      "class": "Blood related therapy",
      "type": "HEMATOPOIETICS",
      "genericName": "Filgrastim (G-CSF)",
      "brandName": "Neupogen",
      "conclusion": "OK!",
      "references": "(G-C web.uct.ac.za/depts/porphyria/) www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "HEMATOPOIETICS",
      "genericName": "Multivitamins",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "HEMOSTATICS",
      "genericName": "Aminocaproic Acid",
      "brandName": "Amicar",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "BLOOD RELATED THERAPY",
      "type": "HEMOSTATICS",
      "genericName": "Aprotinin",
      "brandName": "Trasylol",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "BONES",
      "type": "BISPHOSPHONATES",
      "genericName": "Alendronate",
      "brandName": "Fosamax",
      "conclusion": "OK!",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Not metabolized Patient reports: safe"
    },
    {
      "class": "Bones",
      "type": "Bisphosphonates",
      "genericName": "Ibandronate",
      "brandName": "Boniva",
      "conclusion": "OK?",
      "references": "Bisphosphonates are not metabolized."
    },
    {
      "class": "BONES",
      "type": "BISPHOSPHONATES",
      "genericName": "Zoledronic Acid",
      "brandName": "Zometa",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed: No P450 inhibition in vitro"
    },
    {
      "class": "Bones",
      "type": "Bisphosponates",
      "genericName": "Risedronate",
      "brandName": "Actonel",
      "conclusion": "OK?",
      "references": "Bisphosphonates are not metabolized"
    },
    {
      "class": "Cardiovascular",
      "type": "ACE INHIBITORS",
      "genericName": "Enalapril (Enalaprilat)",
      "brandName": "Vasotec",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic 2 Patient reports: Safe No transactivation of pregnane X receptor (Curr Drug Metab 6:375,2006)"
    },
    {
      "class": "Cardiovascular",
      "type": "ACE INHIBITORS",
      "genericName": "Lisinopril",
      "brandName": "Prinivil",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic P4 atient reports: Safe No transactivation of pregnane X receptor (Curr Drug Metab 6:375,2006)"
    },
    {
      "class": "Cardiovascular",
      "type": "ACE INHIBITORS",
      "genericName": "Ramipril",
      "brandName": "Altace",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic Patient reports: Safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANGIOTENSIN II RECEPTOR ANTAGONISTS",
      "genericName": "Candesartan Cilexetil",
      "brandName": "Atacand",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe, Metab by CYP2C9."
    },
    {
      "class": "Cardiovascular",
      "type": "ANGIOTENSIN II RECEPTOR ANTAGONISTS",
      "genericName": "Losartan",
      "brandName": "Cozaar",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. >2 clinical reports: safe. Substrate of mainly CYP2C9, lesser of CYPs 3A4, 3A5. No data pointing to CYP induction. Safe in cell culture. (Biochem Pharmacol 1999;58:887;Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Cardiovascular",
      "type": "ANGIOTENSIN II RECEPTOR ANTAGONISTS",
      "genericName": "Olmesartan",
      "brandName": "Benicar",
      "conclusion": "OK!",
      "references": "Virtually not metabolized (PDR 63:1009,2009). 1 patient report: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANGIOTENSIN II RECEPTOR ANTAGONISTS",
      "genericName": "Valsartan",
      "brandName": "Diovan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Some metabolism by CYP2C9. Patient reports: Safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANGIOTENSIN RECEPTOR ANTAGONISTS",
      "genericName": "Eprosartan",
      "brandName": "Teveten",
      "conclusion": "OK!",
      "references": "98% excreted unchanged, 2% as glucuronide."
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIADRENERGICS",
      "genericName": "Doxazosin",
      "brandName": "Cardura",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution PV Tishler MD clinical data: Safe Br J Clin Pharmacol 1997;43:339. Safe at <10mg/d. patient report: safe (5 yrs)"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Atorvastatin",
      "brandName": "Lipitor",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Patient report - safe Mainly metab by CYP3A4, but very low likelihood of CYP3A4 induction (Clin Pharmacol Therap 80:565,2006; Curr Drug Metab 7:375,2006) 4 patient reports: Safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Colestipol",
      "brandName": "Colestid",
      "conclusion": "OK!",
      "references": "Not absorbed. Patient reports: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Fluvastatin",
      "brandName": "Lescol",
      "conclusion": "OK?",
      "references": "Mainly metab by CYP2C9, also 3A4. Minimal transactivation of pregnane X receptor (Clin Pharmacol Therap 80:565,2006; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Cardiovascular",
      "type": "Antihyperlipidemic Agents",
      "genericName": "Lovastatin",
      "brandName": "Mevacor, etc",
      "conclusion": "BAD?",
      "references": "Readily absorbed by liver. Metabolized by & induces CYP3A, 2C9. Induces PXR."
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Pravastatin",
      "brandName": "Pravachol",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Substrate of CYP3A, but excreted mostly unchanged, and does not induce CYPs (Mol Pharmacol 65:1302,2004;Clin Pharm Therap 80:565,2006) Experience of P. Tishler, MD and others - safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Rosuvastatin",
      "brandName": "Crestor",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe. Metab by CYP2C9; not metab. by CYP3A4,5. patient report: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Simvastatin",
      "brandName": "Zocor, others",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Patient experience - safe web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in animals Unsafe in cell culture (Biomed Pharmacother 43:135,1989). Mainly metab by CYP3A4,but very low likelihood of CYP3A4 induction (Clin Pharm Therap 80:565,2006;Curr Drug Metab 7:375,2006); strong pregnane xenobiotic activator (J Pharm Exp Therap 320:72, 2007). Patient reports: Safe"
    },
    {
      "class": "Cardiovascular",
      "type": "ANTIOGENSIN RECEPTOR ANTAGONISTS",
      "genericName": "Telmisartan",
      "brandName": "Micardis",
      "conclusion": "OK!",
      "references": "Only metabolite is glucuronide (J Clin Pharm 2000: 40 (12 pt 1), 1312."
    },
    {
      "class": "Cardiovascular",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Labetalol",
      "brandName": "Normodyne, Trandate",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients patient report: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Metoprolol",
      "brandName": "Lopressor",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data & patient report: Safe Medicine (Balt)1992;71:1. Safe. Induces CYP3A."
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Amlodipine",
      "brandName": "Norvasc",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Not safe in patients (Ann Pharmacother 1997;31:253) Safe at <10mg/d (Br J Clin Pharmacol 1997;43:339) Substrate of & induces CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Induces pregnane X receptor. 4 patient reports: Safe, certainly at 5 mg/day."
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Diltiazem",
      "brandName": "Cardizem",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe Substrate of & inhibitor of CYP3A4. Modest transactivation of pregnane X receptor, but low probability of CYP3A4 induction (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; http://medicine.iupui.edu/clinpharm/ddis/; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Felodipine",
      "brandName": "Plendil",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Substrate of & inducer of CYP3A4. Modest transactivator of pregnane X receptor, metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Nicardipine",
      "brandName": "Cardene",
      "conclusion": "BAD!",
      "references": "Induces CYP3A4, 2C9; inhibits 3A. Transactivates pregnane X receptor (Drug Metab Disp 29:1325,2001)"
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Nifedipine",
      "brandName": "Procardia, Adalat",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Medicine (Balt) 1992;71:1. Safe Clin Sci (Lond) 1985;69:581. Unsafe in cell culture Substrate of CYP3A4. Induces CYP3A4, 2C9 via transactivation of pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Drug Metab Disp 29:1325,2001) Patient report: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Verapamil",
      "brandName": "Verapamil, Tarka",
      "conclusion": "OK?",
      "references": "Metab by & inhibits induction of CYP3A4.(http://medicine.iupui.edu/clinpharm/ddis/; Amer J Therap 16:155, 2009; Curr Drug Metab 5:543,2004)"
    },
    {
      "class": "Cardiovascular",
      "type": "DIURETICS",
      "genericName": "Furosemide",
      "brandName": "Lasix",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in patients PV Tishler MD clinical data & patient reports: Safe Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "Cardiovascular",
      "type": "DIURETICS",
      "genericName": "Spironolactone",
      "brandName": "Aldactone",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in animals Safe (Medicine (Balt) 1992;71:1, 1992). Induces CYP3A. Transactivates pregnane X receptor (Expert Opin Drug Metab Toxicol 4:895,2008)"
    },
    {
      "class": "Cardiovascular",
      "type": "DIURETICS",
      "genericName": "Torsemide",
      "brandName": "Demadex, others",
      "conclusion": "OK?",
      "references": "~75% metab, mostly by CYP2C9 (Br J Clin Pharm 50:573,2000; Clin Pharmacol Therap 76:557,2004). 2 Patient reports: safe"
    },
    {
      "class": "Cardiovascular",
      "type": "IMPOTENCE AGENTS",
      "genericName": "Sildenafil",
      "brandName": "Viagra",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Major metab by CYP3A4, less by CYP2C9; weak inhibitors of both (Drug Metab Disp 36:986,2008). Patient report: Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ACE INHIBITORS",
      "genericName": "Benazepril",
      "brandName": "Lotensin",
      "conclusion": "OK!",
      "references": "Patient report: safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ACE INHIBITORS",
      "genericName": "Captopril",
      "brandName": "Capoten",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic. Patient report: safe No transactivation of pregnane X receptor (Curr Drug Metab 6:375,2006)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ACE INHIBITORS",
      "genericName": "Trandolapril",
      "brandName": "Mavik",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANGIOTENSIN II RECEPTOR ANTAGONISTS",
      "genericName": "Irbesartan",
      "brandName": "Avapro, Avalide",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic Mostly not metab by CYPs. Some metab by CYP2C9, but doessnot induce any CYP (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; PDr 63:892,2009)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIADRENERGICS",
      "genericName": "Clonidine",
      "brandName": "Catapres",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients and cell culture"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIADRENERGICS",
      "genericName": "Methyldopa",
      "brandName": "Aldomet",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid Patient report: Unsafe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIADRENERGICS",
      "genericName": "Prazosin",
      "brandName": "Minipress",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe Medicine (Balti) 1992:71:1. Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIADRENERGICS",
      "genericName": "Terazosin",
      "brandName": "Hytrin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution No transactivation of pregnane X receptor (Curr Drug Metab 6:375,2009)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIANGINAL AGENTS",
      "genericName": "Isosorbide Dinitrate",
      "brandName": "Imdur",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIANGINAL AGENTS",
      "genericName": "Nitroglycerin",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "Not a CYP substrate (Biochem. J 1993; 292:545)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Adenosine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Not metabolized by P450"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Amiodarone",
      "brandName": "Many",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in cell culture Gen Pharmacol 1999;32:259. Safe Probably mostly metab by CYP3A4. Induces but more strongly inhibits CYP3A4 (J Pharm Pharm Sci 11:147,2008; Clin Pharm Therap 77:63, 2005)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Bretylium",
      "brandName": "Bretylol",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Disopyramide",
      "brandName": "Norpace",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Flecainide",
      "brandName": "Tambocor, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Metabolized by CYP2D6. No data pointing to CYP-induction (http://medicine.iupui.edu/clinpharm/ddis/)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Ibutilide",
      "brandName": "Corvert",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Circulation 1998;97:493. Metabolic pathway does not seem to involve CYP3A4 or CYP2D6"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Lidocaine",
      "brandName": "Xylocaine",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Porphyrinogenic metab by CYP3A4, 1A2. May ihibit its metab (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007: Pharmacol 1990; 255:1385; Curr Drug Metab 5:543, 2004)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Mexiletine",
      "brandName": "Mexitil",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Metabolized by CYP2D6, 1A2. No data pointing to CYP-induction (Clin Pharmacokinet 46:985,2007)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Moricizine",
      "brandName": "Ethmozine",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Procainamide",
      "brandName": "Pronestyl",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Propafenone",
      "brandName": "Rhthmol",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Metabolized by CYP2D6, 3A4, others; relative importances not known (Curr Drug Metab 5:543,2004; Clin Pharmacokinet 46:985,2007)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Quinidine",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Substrate of CYP3A4. Minimal transactivation of pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIARRHYTHMICS",
      "genericName": "Tocainide",
      "brandName": "Tonocard",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Cholestyramine",
      "brandName": "Questran",
      "conclusion": "OK!",
      "references": "Not absorbed from GI tract"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Clofibrate",
      "brandName": "Atromid-S",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Ezetimibe",
      "brandName": "Zetia, Vitorin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Undergoes minimal oxidation. Extensively metabolized but not by CYP (PDR 63:2149,2009) Patient report: Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Gemfibrozil",
      "brandName": "Lopid",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution Metab by CYP2C8. Minimally transactivates pregnane X receptor (Drug Metab Disp 34:191,2006; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERLIPIDEMIC AGENTS",
      "genericName": "Niacin",
      "brandName": "Many",
      "conclusion": "No info",
      "references": "USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Not P450 substrate"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERTENSIVE - RENIN INHIBITOR",
      "genericName": "Aliskiren",
      "brandName": "Tekturna",
      "conclusion": "OK?",
      "references": "~20% metab, mainly by CYP3A4; does not induce CYP3A4 (Pharmacol Rpts 60:623,2008; J clin Pharmacol 48:1323,2008)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "ANTIHYPERTENSIVE- DUAL AGENT",
      "genericName": "Aliskiren/ Amlodipine",
      "brandName": "Tekamlo",
      "conclusion": "BAD?",
      "references": "See individual drug listings."
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS",
      "genericName": "Nebivolol",
      "brandName": "Bystolic",
      "conclusion": "OK?",
      "references": "Extensively metab by CYP2D6 (Med Letter 50:17,2008). Patient experience: safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Acebutolol",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use Medicine (Balt)1992; 71:1. Safe biocomp.health.unm.edu/p450/metabP450diseasep4.pdf: Substrate/inhibitor of CYP2D6"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Atenolol",
      "brandName": "Tenormin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/ safe in patients PV Tishler MD clinical data & patient reports: Safe Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Betaxolol",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Carteolol",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Esmolol",
      "brandName": "Brevibloc",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Nadolol",
      "brandName": "Corgard",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Pindolol",
      "brandName": "Visken",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Propranolol",
      "brandName": "Inderal",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use PV Tishler MD clinical data & patient report: Safe Safe (Br J Clin Pharmacol 1997;43:339) Safe (Medicine (Balt) 1992;71:1) Substrate of CYP3A4 & other CYPs. Does not transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; http://medicine.iupui.edu/clinpharm/ddis/)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Sotalol",
      "brandName": "Betapace, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "BETA BLOCKERS (includes some ophthalmic preparations)",
      "genericName": "Timolol",
      "brandName": "Blocadren",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture Medicine (Balt)1992;71:1. Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Amlodipine/ olmesartan",
      "brandName": "Azor",
      "conclusion": "BAD?",
      "references": "See amlodipine"
    },
    {
      "class": "Cardiovascular agents",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Bepridil",
      "brandName": "Vascor",
      "conclusion": "BAD!",
      "references": "www.uq.edu.au/porphyria/: Unsafe in cell culture Williams DA: Op. Cit.: Substrate of CYP3A4"
    },
    {
      "class": "Cardiovascular agents",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Clevidipine",
      "brandName": "Cleviprex",
      "conclusion": "OK?",
      "references": "Unlikely inducer of CYPs at therapeutic doses (Drug Metab Disp 34:734,2006)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "CALCIUM CHANNEL BLOCKERS",
      "genericName": "Nimodipine",
      "brandName": "Nimotop",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "CARDIAC GLYCOSIDES",
      "genericName": "Digoxin",
      "brandName": "Lanoxin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in patients Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Acetazolamide",
      "brandName": "Diamox",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients & cell culture"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Amiloride",
      "brandName": "Midamor, Moduretic, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Bumetanide",
      "brandName": "Bumex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Patient report: Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Eplerenone",
      "brandName": "Inspra",
      "conclusion": "BAD?",
      "references": "~95% metab, mainly by CYP3A4. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; J Clin Pharmacol 45:810,2005; Am J Therapeutics 16:255,2009)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Ethacrynic Acid",
      "brandName": "Edecrin",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients http://www.emedicine.com/MED/topic1880.htm: Safe in porphyria"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Hydrochlorothiazide",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data & patient reports: Safe"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DIURETICS",
      "genericName": "Metolazone",
      "brandName": "Zaroxolyn",
      "conclusion": "BAD?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "CARDIOVASCULAR AGENTS",
      "type": "DIURETICS",
      "genericName": "Triamterene",
      "brandName": "Dyrenium",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "DOPAMINE D1 RECEPTOR AGONISTS",
      "genericName": "Fenoldopam",
      "brandName": "Corlopam",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "IMPOTENCE AGENTS",
      "genericName": "Tadalafil",
      "brandName": "Cialis",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.premiumdrugs.com/globalcart/ html/media/docs/cialis-pi-us.pdf: metabolized primarily by CYP3A4"
    },
    {
      "class": "Cardiovascular agents",
      "type": "IMPOTENCE AGENTS",
      "genericName": "Vardenafil",
      "brandName": "Levitra",
      "conclusion": "No info",
      "references": "Major metab by CYP3A4, 3A5 (Drug Metab Disp 36:986,2008)"
    },
    {
      "class": "Cardiovascular agents",
      "type": "MISC.",
      "genericName": "Diazoxide",
      "brandName": "Hyperstat",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture"
    },
    {
      "class": "Cardiovascular agents",
      "type": "MISC.",
      "genericName": "Tolazoline",
      "brandName": "Priscoline",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients http://www.emedicine.com/MED/topic1880.htm: Safe in porphyria"
    },
    {
      "class": "Cardiovascular agents",
      "type": "PHOSPHODIESTERASE INHIBITORS",
      "genericName": "Milrinone",
      "brandName": "Primacor",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "Cardiovascular agents",
      "type": "THROMBOLYTIC ENZYMES",
      "genericName": "Alteplase",
      "brandName": "Activase",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Cardiovascular agents",
      "type": "THROMBOLYTIC ENZYMES",
      "genericName": "Streptokinase",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "THROMBOLYTIC ENZYMES",
      "genericName": "Tenecteplase",
      "brandName": "Tnkase",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASODILATORS",
      "genericName": "Hydralazine",
      "brandName": "Apresoline",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASODILATORS",
      "genericName": "Minoxidil",
      "brandName": "Many",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASODILATORS",
      "genericName": "Nitroprusside",
      "brandName": "Nipride",
      "conclusion": "OK?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Caution Redox Rep 2004;9:360: No P450 metabolism"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASOPRESSORS",
      "genericName": "Dobutamine",
      "brandName": "Dobutrex, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASOPRESSORS",
      "genericName": "Dopamine",
      "brandName": "Intropin, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Cardiovascular agents",
      "type": "VASOPRESSORS",
      "genericName": "Ephedrine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Carbamazepine",
      "brandName": "Tegretol",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients Unsafe/risky in patients (Epilepsia 33:108,1992; Neurology 32:1409,1982; Neurology 45:1216,1995). Major metab by CYP3A4. Induces CYP3A4 via transactivation of constitutive androstane receptor & kpregnane X receptor. Also induces CYP2C9, other CYPs. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch toxicol 82:667,2008; Clin Therapeutics 30:1385,2008) Patient report: Safe (low dose)"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Gabapentin",
      "brandName": "Neurontin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use PV Tishler MD clinical data & patient reports: Safe Not a substrate for & does not induce CYPs (Fundam Clin Pharmacol 14:301,2000; Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Phenytoin",
      "brandName": "Dilantin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients Unsafe in patients (Neurology 45:1216,1995; Epilepsia 33:108,1992) Substrate & inducer of CYP3A4 & CYP2C9. Strongly activates constitutive androstane receptor & pregnane X receptor, & induces CYP3A4. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; JBC 279:29295,2004; Arch Toxicol 82:667,2008) 1 Patient report: Safe. 1 patinet report: unsafe"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Pregabalin",
      "brandName": "Lyrica",
      "conclusion": "OK!",
      "references": ">90% non-metabolized (PDR 63:2527,2009). Patient reports: safe"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Topiramate",
      "brandName": "Topomax",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably porphyrinogenic. www.porphyria.uct.ac.za: Use only with extreme caution. 30-40% metabolized, some by CYP2C9; metab by CYP3A4 probably minimal, but induces CYP3A4 via transactivation of pregnane X receptor (Pharmacokinet 45:1061,2006; Epilepsia 46:378,2005; Arch Toxicol 82:667,2008; Clin Therapeutics 30:1385,2008) 1 patient report: safe"
    },
    {
      "class": "Central nervous system",
      "type": "ANTICONVULSANTS",
      "genericName": "Valproic Acid",
      "brandName": "Depakene, Stavzor",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid www.porphyriafoundation.com: Unsafe Largely not CYP metab; some metab by multiple CYP2C9 but not CYP3A4. Induces CYP3A. Does not transactivate pregnane X receptor. (Clin Therapeutics 30:1385,2008; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Central nervous system",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Ropinirole",
      "brandName": "Roquid",
      "conclusion": "OK?",
      "references": "~90% metab by CYP1A2, small amt by CYP3A (Clin Pharmacokinet 39:243,2000). 1 patient report: safe."
    },
    {
      "class": "Central nervous system",
      "type": "Antispasmodic",
      "genericName": "Trospium",
      "brandName": "Sanctura",
      "conclusion": "OK!",
      "references": "Ester hydrolysis, with probably littel/no P450 metabolism. 1 patient report: safe."
    },
    {
      "class": "Central nervous system",
      "type": "BENZODIAZEPINES",
      "genericName": "Alprazolam",
      "brandName": "Xanax",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in cell culture Mainly metab by CYP3A4, but does not transactivate pregnane X receptor (USP DI? Drug Info. for the Health Care Pro. - 26th Ed; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metrab 7:375,2006) >1Patient reports: Safe"
    },
    {
      "class": "Central nervous system",
      "type": "BENZODIAZEPINES",
      "genericName": "Diazepam",
      "brandName": "Valium",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Unsafe in patients Medicine (Balt) 1992;71:1. Safe Substrate of CYP3A4,2B6,2C9. Modest transactivator of pregnane X receptor, but low prediction of CYP3A4 inducibility (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; Curr Drug Metab 9:598,2008) 2 Patient reports: Safe"
    },
    {
      "class": "Central nervous system",
      "type": "BENZODIAZEPINES",
      "genericName": "Temazepam",
      "brandName": "Restoril",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007) 2 Patient reports: Safe"
    },
    {
      "class": "Central nervous system",
      "type": "BENZODIAZEPINES",
      "genericName": "Triazolam",
      "brandName": "Halcion",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals Medicine (Balt) 1992;71:1. Safe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007). 1 patientreport: safe."
    },
    {
      "class": "Central nervous system",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Chloral Hydrate",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe www.uq.edu.au/porphyria/: Safe in patients Peter V. Tishler, MD, clinical experience: safe patient report: safe"
    },
    {
      "class": "Central nervous system",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Zolpidem",
      "brandName": "Ambien, Edluar, Intermezzo, Zolpimist",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic CYP3A substrate. Moderate transactivator of pregnane X receptor, but low prediction of CYP3A4 inducibility (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007;http://medicine.iupui.edu/flockhart/table.htm; Curr Drug Metab 7:375,2006) 6 Patient reports: safe"
    },
    {
      "class": "Central nervous system",
      "type": "MIGRAINE THERAPY",
      "genericName": "Sumatriptan",
      "brandName": "Imitrex",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution 2 patient reports: safe"
    },
    {
      "class": "Central nervous system",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Fentanyl",
      "brandName": "Duragesic",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals Substrate of & induces CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007).Induces pregnane X receptor Patient reports: Safe"
    },
    {
      "class": "Central nervous system",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Methadone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: safe web.uct.ac.za/depts/porphyria/: Use Metab by CYP3A, less by 2C9."
    },
    {
      "class": "Central nervous system",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Tramadol",
      "brandName": "Ultram, Ultracet, Ryzolt, etc.",
      "conclusion": "No info",
      "references": "Largely metab by CYP3A4,2D6 (Eur J Clin Pharm 62:513,2006). Patient report: safe"
    },
    {
      "class": "Central nervous system",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Acetaminophen",
      "brandName": "Tylenol",
      "conclusion": "OK!",
      "references": "www.porphyriafoundation.com: Safe PV Tishler MD clinical data & patient reports: Safe Induces constitutive androstene receptor."
    },
    {
      "class": "Central nervous system",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Ibuprofen",
      "brandName": "Advil, Motrin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe. Metab by CYP2C9,2C8. PV Tishler MD clinical data & patient reports: Safe at low dose used intermittently, BUT one acute attack at high, prolonged dose (Drug Metab Disp 33:1567, 2005) patient reports: safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "AMPHETAMINES",
      "genericName": "Dextroamphetamine",
      "brandName": "Dexedrine",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "Anti-Glaucoma",
      "genericName": "Brinzolamide/ Brimonidine",
      "brandName": "Simbrinza",
      "conclusion": "BAD!",
      "references": "Brinzolamide is a sulfonamide, and thus this is contraindicated"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Clonazepam",
      "brandName": "Klonopin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe www.porphyriafoundation.com: unsafe Epilepsia 1992;33:108. porphyrogenic but safe in lose dosages Neurology 1982;32:1409. safe in low dosages Greatly induces CYP2B. Substrate of but does not induce CYP3A or 2C9 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Drug Metab Dispos 25:750,1997)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Divalproex",
      "brandName": "Depakote",
      "conclusion": "OK?",
      "references": "Dimer of valproic acid. See Valproic acid."
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Ethosuximide",
      "brandName": "Zarontin",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Unsafe in animals (Neurology 1981;31:480) Substrate of CYP3A4, but does not transactivate pregnane X receptor. Minor metab by CYP2C9, other CYPs (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375, 2006; Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Felbamate",
      "brandName": "Felbatol",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.porphyriafoundation.com: Unsafe Metab mainly by CYP3A4, also 2C9, others. Induces CYP3A4 but does not transactivate pregnane X receptor (Fundam Clin Pharmacol 14:301,2000; Curr Drug Metab 7:375,2006; Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Fosphenytoin",
      "brandName": "Cerebyx",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic Metab mainly by CYP2C9, also CYP3A4, others. Induces CYP2C9,3A4 (Clin Therapeutics 30:1385,2008. Same as Phenytoin."
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Levetiracetam",
      "brandName": "Keppra",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe Not a substrate for & does not induce CYPs (Fundam Clin Pharmacol 14:301,2000; Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Methsuximide",
      "brandName": "Celontin",
      "conclusion": "BAD!",
      "references": "www.uq.edu.au/porphyria/: Unsafe in patients Neurology 1981;31:480. Unsafe in animals"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Oxcarbazepine",
      "brandName": "Trileptal",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid Induces CYP3A4 (Fundam Clin Pharmacol 14:301,2000)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Phenobarbital",
      "brandName": "Luminal",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid Strongly activates constitutive androstane receptor, pregnane X receptor, & induces CYP3A4 (BBRC 277:1, 2000; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Primidone",
      "brandName": "Mysoline",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Neurology 1981;31:480. Unsafe in animals. Metab by CYP3A4 to phenobarbital (BAD!!); induces CYP3A4 (Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTICONVULSANTS",
      "genericName": "Zonisamide",
      "brandName": "Zonegran",
      "conclusion": "BAD?",
      "references": "Major metab by CYP3A4; also CYP2C19. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Clin Therapeutics 30:1385,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIMYASTHENIC AGENTS",
      "genericName": "Ambenonium",
      "brandName": "Mytelase",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIMYASTHENIC AGENTS",
      "genericName": "Edrophonium",
      "brandName": "Tensilon",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIMYASTHENIC AGENTS",
      "genericName": "Guanidine",
      "brandName": "Guanidine",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIMYASTHENIC AGENTS",
      "genericName": "Neostigmine",
      "brandName": "Prostigmine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIMYASTHENIC AGENTS",
      "genericName": "Pyridostigmine",
      "brandName": "Mestinon",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution. Patient report: safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Amantadine",
      "brandName": "Symmetrel",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Benztropine",
      "brandName": "Cogentin",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Bromocriptine",
      "brandName": "Parlodel",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in cell culture Metab by CYP3A4 (Clin Therapeutics 28:1065,2006)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Entacapone",
      "brandName": "Comtan, Stalevo",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic. Not metab by CYPs (PDR 63:2208, 2009)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Levodopa",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Caution USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Not P450 substrate http://www.ukmi.nhs.uk/NewMaterial/ html/docs/entacapo.pdf: Main metabolic pathway does not involve P450"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Levodopa/ Carbidopa",
      "brandName": "Sinemet",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Pergolide",
      "brandName": "Permax",
      "conclusion": "No info",
      "references": "metab by CYP3A4 (Clin Therapeutics 28:2065,2006)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Pramipexole",
      "brandName": "Mirapex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: ~90% excreted unchanged. No CYP metab (Eur J Neurol 7 Suppl 1:15,2000)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Rotigotine",
      "brandName": "Neupro (patch)",
      "conclusion": "OK?",
      "references": "Metab by multiple CYPs. Does not induce CYP3A4, 2C9 (PDR 63:3149,2009)"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Selegiline",
      "brandName": "Emsam, Eldepryl, Zelapar",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Metab by CYP2B6, which may involve pregnane X receptor"
    },
    {
      "class": "Central nervous system agents",
      "type": "ANTIPARKINSON AGENTS",
      "genericName": "Trihexyphenidyl",
      "brandName": "Artane",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid"
    },
    {
      "class": "Central nervous system agents",
      "type": "BENZODIAZEPINES",
      "genericName": "Chlordiazepoxide",
      "brandName": "Librium",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients Medicine (Balt) 1992;71:1. Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "BENZODIAZEPINES",
      "genericName": "Estazolam",
      "brandName": "Prosom",
      "conclusion": "OK?",
      "references": "www.uq.edu.au/porphyria/: Cell cuture - probably safe PV Tishler MD clinical data: Safe Metab. almost exclusively by CYP3A4 (https://online.epocrates.com/front_porch/; Xenobiotica 35:455,2005)"
    },
    {
      "class": "Central nervous system agents",
      "type": "BENZODIAZEPINES",
      "genericName": "Flurazepam",
      "brandName": "Dalmane",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Central nervous system agents",
      "type": "BENZODIAZEPINES",
      "genericName": "Lorazepam",
      "brandName": "Ativan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe Not metab by CYPs (Curr Drug Metab 9:827,2008) PV Tishler MD clinical data: Safe Medicine (Balt) 1992;7:1. Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "BENZODIAZEPINES",
      "genericName": "Oxazepam",
      "brandName": "Serax",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe. Not metab by CYPs (Curr Drug Metab 9:827,2008)"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Butabarbital",
      "brandName": "Butisol",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe. See phenobarbital"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Butalbital",
      "brandName": "Fiorinal",
      "conclusion": "BAD!",
      "references": "See phenobarbital"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Eszopiclone",
      "brandName": "Lunesta",
      "conclusion": "OK?",
      "references": "Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Ethchlorvynol",
      "brandName": "Placidyl",
      "conclusion": "BAD!",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Pentobarbital",
      "brandName": "Nembutal",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe Patient report: Unsafe See Phenobarbital"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Ramelteon",
      "brandName": "Rozerem",
      "conclusion": "BAD?",
      "references": "Patient report - bad. Minor metab. by CYP3A4."
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Secobarbital",
      "brandName": "Seconal",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe Induces CYP3A4 (Arch Toxicol 82:667,2008) See Phenobarbital"
    },
    {
      "class": "Central nervous system agents",
      "type": "HYPNOTICS (Sleeping Medications)",
      "genericName": "Zaleplon",
      "brandName": "Sonata",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Metabolized by CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Xenobiotica 2002;32:835) Patient reports: Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "MIGRAINE THERAPY",
      "genericName": "Ergotamine",
      "brandName": "Cafergot",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Central nervous system agents",
      "type": "MIGRAINE THERAPY",
      "genericName": "Isometheptene/ Dichloralphenazone",
      "brandName": "Midrin, others",
      "conclusion": "BAD?",
      "references": "Isometheptene www.uq.edu.au/porphyria/: Unsafe in animals Dichloralphenazone www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Central nervous system agents",
      "type": "MIGRAINE THERAPY",
      "genericName": "Naratriptan",
      "brandName": "Amerge",
      "conclusion": "NO INFO",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic"
    },
    {
      "class": "Central nervous system agents",
      "type": "MIGRAINE THERAPY",
      "genericName": "Rizatriptan",
      "brandName": "Maxalt",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic No significant interaction with CYPs. Primary metabolism does not involve CYPs (PDR 63:2056,2009; www.cbg-meb.nl/uk/docs/nieuws/par-maxalt.pdf)"
    },
    {
      "class": "Central nervous system agents",
      "type": "MIGRAINE THERAPY",
      "genericName": "Zolmitriptan",
      "brandName": "Zomig",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Insufficient data on metabolism. One report (Swedish) of tolerance. Xenobiotica 1999;29:847. Metabolized almost entirely by CYP1A2. Sinz M: Cur Drug Metab 2006; 7:375. No activation of pregnane X receptor."
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Alfentanil",
      "brandName": "Alfenta",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use Substrate ~equally of CYP3A4, 3A5 (Williams DA. Drug metabolism. In: Foye?s Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Drug Metab Disp 33:303,2005)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Buprenorphine",
      "brandName": "Buprenex, Suboxone, Subutex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data: Safe Ann Fr Anesth Reanim 1989;8:525. Safe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Butorphanol",
      "brandName": "Stadol",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Codeine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data & patient report: Safe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Hydrocodone",
      "brandName": "Vicodin, others",
      "conclusion": "OK!",
      "references": "see Respiratory Agents/antitussive Agents"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Hydromorphone",
      "brandName": "Dilaudid",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Meperidine",
      "brandName": "Demerol",
      "conclusion": "OK!",
      "references": "PV Tishler MD clinical data: Safe JAMA 1965;194:1037. Safe in patients"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Morphine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data: Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Nalbuphine",
      "brandName": "Nubain",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Oxycodone",
      "brandName": "Oxycontin, Percocet, Percodan, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.uq.edu.au/porphyria/: Unsafe in animals PV Tishler MD clinical data & patient reports: Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "NARCOTICS (Pain Therapies)",
      "genericName": "Pentazocine",
      "brandName": "Talwin",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Aspirin",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients www.porphyriafoundation.com: Safe PV Tishler MD clinical data & patient reports: Safe"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Diclofenac",
      "brandName": "Voltaren",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe PV Tishler MD clinical data: Safe Biomed Pharmacother 43:135,1989 - Unsafe in cell culture Limited metab by CYP2C9, ?2C8 (Drug Metab Disp 33:1567, 2005)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Indomethacin",
      "brandName": "Indocin",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe. ~50% metab by CYP2C9 (Drug Metab Disp 33:1567, 2005). Medicine (Balt) 71:1, 1992 - Safe in some, not safe in others"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Ketoprofen",
      "brandName": "Orudis, Oruvail, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution Probably not metab by CYPs PV Tishler MD clinical data: Safe (Drug Metab Disp 33:1567,2005)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Ketorolac Tromethamine",
      "brandName": "Toradol",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Eksp Klin Farmakol. 2005;68:56. CYP2C substrate"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Naproxen",
      "brandName": "Naprosyn, Aleve",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients and animals 20-40% metab by CYP2C9 (<50% of this), other CYPs Patient reports: Safe (Drug Metab Disp 33:1567,2005)"
    },
    {
      "class": "Central nervous system agents",
      "type": "NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -NSAIDs (Pain, Arthritis Therapies, etc.)",
      "genericName": "Sulindac",
      "brandName": "Clinoril",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals Minimal CYP2D9 metab (Drug Metab Disp 33:1567,2005)"
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Diatrizoate Meglumine",
      "brandName": "Hypaque",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Ethiodized Oil",
      "brandName": "Ethiodol",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Ferumoxides",
      "brandName": "Endorem",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Gadopentetate Dimeglumine",
      "brandName": "Magnevist",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Iodipamide Meglumine",
      "brandName": "Chlorografin, Sinografin",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Contrast media",
      "type": "n/a",
      "genericName": "Iodixanol",
      "brandName": "Visipaque",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.fda.gov/medwatch/SAFETY/ 2003/03DEC_PI/Visipaque_PI.pdf: No metabolism"
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Iohexol",
      "brandName": "Omnipaque",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Iopanoic Acid",
      "brandName": "Telepaque",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "CONTRAST MEDIA",
      "type": "n/a",
      "genericName": "Iopromide",
      "brandName": "Ultravist",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Dermatologicals",
      "type": "ACNE",
      "genericName": "Isotretinoin",
      "brandName": "Accutane, Sotret, Amnesteem, Claravis",
      "conclusion": "BAD?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution Substrate of CYP3A4. Minimally transactivates pregnane X receptor, and has low proability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Dermatologicals",
      "type": "ANTIPSORIATICS - SYSTEMIC",
      "genericName": "Acitretin",
      "brandName": "Soriatane",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "Dermatologicals",
      "type": "Dermatosis, allergy, psoriasis",
      "genericName": "desoximetasone",
      "brandName": "topicort",
      "conclusion": "OK?",
      "references": "Topical corticosteroid. 1 patinet report: safe"
    },
    {
      "class": "Diagnostic",
      "type": "n/a",
      "genericName": "Methacholine",
      "brandName": "Provocholine, others",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "Diagnostic",
      "type": "Imaging",
      "genericName": "Gadobutrol",
      "brandName": "Gadavist",
      "conclusion": "OK!",
      "references": "MRI contrast agent that is not metabolized"
    },
    {
      "class": "Gastrointestinal",
      "type": "ANTIDIARRHEAL AGENTS",
      "genericName": "Rifaximin",
      "brandName": "Xifaxan",
      "conclusion": "OK!",
      "references": ">99% excreted in feces unabsorbed/unchanged (PDR 65:2911, 2011). Induces pregnane X receptor."
    },
    {
      "class": "Gastrointestinal",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Dronabinol",
      "brandName": "Marinol",
      "conclusion": "BAD?",
      "references": "Major metab by CYP3A4 & 2C9 (Williams DA. Induces pregnane X receptor. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Gastrointestinal",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Meclizine",
      "brandName": "Antivert, Bonine",
      "conclusion": "OK!",
      "references": ">3 patient reports: safe. Induces & inhibits constitutive androstene receptor."
    },
    {
      "class": "Gastrointestinal",
      "type": "ANTISPASMODICS",
      "genericName": "Dicyclomine",
      "brandName": "Bental, others",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients Patient reports: Safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "ANTISPASMODICS",
      "genericName": "Hyoscyamine",
      "brandName": "Levsin, others",
      "conclusion": "OK!",
      "references": "3 patient reports: safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Cimetidine",
      "brandName": "Tagamet",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe Clin Chim Acta 1995;234:171. Safe in patients Ann Int Med 2005; 143:694. Safe and possibly therapeutic during acute attack. PV Tishler, MD clinical data & patient reports: Safe Substrate % inhibitor of CYP3A4 but does not transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Gastrointestinal",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Famotidine",
      "brandName": "Pepcid",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in patients Patient reports: Safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Omeprazole",
      "brandName": "Prilosec",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Substrate & inducer of CYP3A4. Significantly transactivates pregnane X receptor, but has low probability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375, 2006; Drug Safety 29:769, 2006) 7 patient reports: safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Rabeprazole",
      "brandName": "Aciphex",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Major metab is nonenzymatic. Minor metab via CYP2C19,3A4. Modestly transactivates pregnane X receptor, but has low probability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; Drug Safety 29:769, 2006). 1 patient report: safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Ranitidine",
      "brandName": "Zantac",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe www.porphyriafoundation.com: Safe PV Tishler MD clinical data: Safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "LAXATIVES",
      "genericName": "Bisacodyl",
      "brandName": "Dulcolax",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution PV Tishler MD clinical data: Safe"
    },
    {
      "class": "Gastrointestinal",
      "type": "POTASSIUM REMOVING RESINS",
      "genericName": "Sodium Polystyrene Sulfonate",
      "brandName": "Kayexalate",
      "conclusion": "OK!",
      "references": "patient report: safe"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTI-INFLAMMATORY AGENTS",
      "genericName": "Infliximab",
      "brandName": "Remicade",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic Protein; no CYP metab"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTI-INFLAMMATORY AGENTS",
      "genericName": "Mesalamine",
      "brandName": "Rowasa, Pentasa, Asacol, others",
      "conclusion": "OK!",
      "references": "<30% absorbed; not metab by CYPs"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTI-INFLAMMATORY AGENTS",
      "genericName": "Olsalazine",
      "brandName": "Dipentum",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic metab to mesalamine which has no CYP metab"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "ANTIDIARRHEAL AGENTS",
      "genericName": "Diphenoxylate",
      "brandName": "Lomotil",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "ANTIDIARRHEAL AGENTS",
      "genericName": "Kaolin-Pectin",
      "brandName": "Kaopectate",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "ANTIDIARRHEAL AGENTS",
      "genericName": "Loperamide",
      "brandName": "Imodium",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in cell culture Patient report: Safe"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Cyclizine",
      "brandName": "Merezine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Dimenhydrinate",
      "brandName": "Dramamine",
      "conclusion": "BAD!",
      "references": "www.porphyria-europe.com: unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Ondansetron",
      "brandName": "Zofran",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution PV Tishler MD clinical data & patient reports: Safe Substrate of CYP3A4. Modestly transactivates pregnane X receptor but has a low probability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Palonosetron",
      "brandName": "Aloxi",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Scopolamine",
      "brandName": "Transderm-Scop, Scopace, Meldemar, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Thiethylperazine",
      "brandName": "Torecan",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "ANTIEMETICS (Vomiting Therapies)",
      "genericName": "Trimethobenzamide",
      "brandName": "Tigan",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "ANTISPASMODICS",
      "genericName": "Atropine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients www.porphyriafoundation.com: Safe"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "ANTISPASMODICS",
      "genericName": "Belladonna Alkaloids",
      "brandName": "Many",
      "conclusion": "BAD?",
      "references": "web.uct.ac.za/depts/porphyria/: Avoid"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "GASTROINTESTINAL MOTILITY STIMULANTS",
      "genericName": "Alvimopan",
      "brandName": "Entereg",
      "conclusion": "OK?",
      "references": "Hepatic/CYP metab unlikely (Clin Pharmacol Therap 83:770,2008; PDR 63:3293,2009; pkg insert)"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "GASTROINTESTINAL MOTILITY STIMULANTS",
      "genericName": "Lubiprostone",
      "brandName": "Amitiza",
      "conclusion": "OK?",
      "references": "No CYP metabolism or induction (PDR 63:3082,2007)"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "GASTROINTESTINAL MOTILITY STIMULANTS",
      "genericName": "Metoclopramide",
      "brandName": "Reglan",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Probably unsafe www.porphyriafoundation.com: Unsafe Lancet 1981;2:91 Not safe However, ~80% not metab by CYP (www.clinicalpharmacology-ip.com)"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Esomeprazole",
      "brandName": "Nexium",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. www.porphyria.uct.ac.za: Use with extreme caution. PV Tishler MD clinical data & patient report: Safe. Major metabolic path via CYP2C19, minor via CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007) ."
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "H-2 Antagonists, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Lansoprazole",
      "brandName": "Pravacid",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably porphyrinogenic. www.porphyria.uct.ac.za: Use but with caution. Metabolsim mainly via CYP2C19. Sinz M: Cur Drug Metab 2006; 7:375: Moderate activation of pregnane X receptor but low prediction of clinical induction."
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "H-2 ANTAGONISTS, PPIs (Reflux, Ulcer Therapies)",
      "genericName": "Pantoprazole",
      "brandName": "Protonix",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution Metabolized by CYP2C19, 3A4. No evidence for CYP3A4 inducibility (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Drug Safety 29:769,2006) 2 Patient reports: Safe"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "LAXATIVES",
      "genericName": "Senna",
      "brandName": "Senokot",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "GASTROINTESTINAL THERAPIES",
      "type": "PHOSPHATE BINDER AGENTS",
      "genericName": "Sevelamer",
      "brandName": "Renagel",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Gastrointestinal therapies",
      "type": "PROSTAGLANDINS",
      "genericName": "Misoprostol",
      "brandName": "Cytotec",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic Not metab by and does not affect CYPs (www.clinicalpharmacology-ip.com)"
    },
    {
      "class": "Hormones",
      "type": "CORTICOSTEROIDS",
      "genericName": "Dexamethasone",
      "brandName": "Decadron",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use Substrate of CYP3A4. Induces CYP3A4, 2C9 via transactivation of pregnane X receptor (modest). Patient report: Safe. MAY BE UNSAFE if used for prolonged periods. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Hormones",
      "type": "CORTICOSTEROIDS",
      "genericName": "Methylprednisolone",
      "brandName": "Medrol,others",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use Substrate & inhibitor of CYP3A4. Induces CYP3A4 via transactivation of pregnane X receptor. Patient report: Safe. MAY BE UNSAFE if used for prolonged periods. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Hormones",
      "type": "ESTROGENS",
      "genericName": "Ethinyl Estradiol",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably safe PV Tishler MD clinical data & patient report: Safe Horm Metab Res 1995;27:379. Safe in patients Mass. College of Pharmacy databse: Substrate & inhibitor of CYP3A4. Inducer of pregnane X receptor."
    },
    {
      "class": "Hormones",
      "type": "ORAL CONTRACEPTIVES",
      "genericName": "Birth Control Pills",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007) 1Patient report: Safe. 3 patient reports: unsafe - ethinyl estradiol/drospirenone (Yasmin), ethinyl estradiol-desogestrel (Orthocoept), ethinyl estradiol-norgestimate (Orcho Cyclen) unsafe"
    },
    {
      "class": "Hormones",
      "type": "PROGESTINS",
      "genericName": "Levonorgestrel",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution. Metab by CYP3A4."
    },
    {
      "class": "Hormones",
      "type": "PROGESTINS",
      "genericName": "Norethindrone",
      "brandName": "Loestrin",
      "conclusion": "No info",
      "references": "JAMA 1965;194:1037. Safe in patients USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Undergoes reduction in liver; induces CYP2C9."
    },
    {
      "class": "Hormones",
      "type": "PROGESTINS",
      "genericName": "Progesterone",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.porphyriafoundation.com: Unsafe Patient report: unsafe. Induces CYP3A, pregnane X receptor"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "ANDROGENS",
      "genericName": "Danazol",
      "brandName": "Danocrine",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic www.porphyria-europe.com: Unsafe web.uct.ac.za/depts/porphyria/: Avoid www.uq.edu.au/porphyria/: Unsafe in patients www.porphyriafoundation.com: Unsafe J Clin Endocrinol Metab 1981;52:549. Exacerbates acute porphyria J Clin Endocrinol Metab 1979;48:123. Unsafe in patients"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "ANDROGENS",
      "genericName": "Methyltestosterone",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "ANDROGENS",
      "genericName": "Nandrolone",
      "brandName": "Deca-Durabolin",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic www.uq.edu.au/porphyria/: Probably unsafe"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "ANDROGENS",
      "genericName": "Oxandrolone",
      "brandName": "Oxandrin",
      "conclusion": "BAD?",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "ANDROGENS",
      "genericName": "Stanozolol",
      "brandName": "Winstrol",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "ANDROGENS",
      "genericName": "Testosterone",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic Substrate of CYP3A4 & CYP2C9. Modestly transactivates pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "CORTICOSTEROIDS",
      "genericName": "Betamethasone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "CORTICOSTEROIDS",
      "genericName": "Cortisone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "CORTICOSTEROIDS",
      "genericName": "Fludrocortisone",
      "brandName": "Florinef",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "CORTICOSTEROIDS",
      "genericName": "Hydrocortisone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably safe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "CORTICOSTEROIDS",
      "genericName": "Prednisolone",
      "brandName": "Many",
      "conclusion": "OK?",
      "references": "Substrate of CYP3A4. Induces CYP3A4 via transactivation of pregnane X receptor. Patient report: Safe. MAY BE UNSAFE if used for prolonged periods. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "CORTICOSTEROIDS",
      "genericName": "Prednisone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use Substrate of CYP3A4. Weakly transactivates pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375, 2006) Patient reports: Safe"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "CORTICOSTEROIDS",
      "genericName": "Triamcinolone",
      "brandName": "Aristocort",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "ESTROGENS",
      "genericName": "Estrogens, Conjugated",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "ESTROGENS",
      "genericName": "Estropipate",
      "brandName": "Ogen, Ortho-est",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "LHRH/GNRH AGONISTS",
      "genericName": "Goserelin",
      "brandName": "Zoladex",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "LHRH/GNRH AGONISTS",
      "genericName": "Leuprolide",
      "brandName": "Lupron",
      "conclusion": "OK?",
      "references": "Protein, metabolized by proteolysis"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "LHRH/GNRH AGONISTS",
      "genericName": "Nafarelin",
      "brandName": "Synarel",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.porphyria-europe.com: Safe"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "OVULATION STIMULANTS",
      "genericName": "Clomiphene",
      "brandName": "Clomid",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "PARATHYROID",
      "genericName": "Calcitonin",
      "brandName": "Miacelcin, Calcimar, Fortical",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.porphyria-europe.com: Safe Patient report: Safe"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Chorionic Gonadotropin",
      "brandName": "Pregnyl",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Desmopressin",
      "brandName": "DDAVP",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Ergonovine",
      "brandName": "Ergotrate",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Menotropins",
      "brandName": "Repronex",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Methylergonovine",
      "brandName": "Methergine",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Oxytocin",
      "brandName": "Pitocin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Urofollitropin",
      "brandName": "Fertinorm",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PITUITARY",
      "genericName": "Vasopressin",
      "brandName": "Pitressin",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "PROGESTINS",
      "genericName": "Medroxyprogesterone",
      "brandName": "Provera",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMs)",
      "genericName": "Raloxifene",
      "brandName": "Evista",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Chang: Drug Metab Disp 2006; 34:2073: bound to P-gycoprotein & activated by CYP3A4. Sinz M: Cur Drug Metab 2006; 7:375: Little activation of human pregnane X receptor & low prediction of clinical induction."
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "SOMATOSTATIC AGENTS",
      "genericName": "Octreotide",
      "brandName": "Sandostatin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "SPERMICIDES (VAGINAL)",
      "genericName": "Nonoxynol-9",
      "brandName": "Many",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "THYROID",
      "genericName": "Levothyroxine",
      "brandName": "Levoxyl, Synthroid",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use PV Tishler MD clinical data & patient reports: Safe"
    },
    {
      "class": "HORMONES, HORMONE-LIKE",
      "type": "THYROID",
      "genericName": "Liothyronine",
      "brandName": "Cytomel",
      "conclusion": "OK!",
      "references": "web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "THYROID",
      "genericName": "Methimazole",
      "brandName": "Tapazole",
      "conclusion": "No info",
      "references": "Metab by liver, presumably by CYPs; inhibits several CYPs also (Drug Metab Dispos 1997;25:390)"
    },
    {
      "class": "Hormones, hormone-like",
      "type": "THYROID",
      "genericName": "Propylthiouracil (PTU)",
      "brandName": "Procasil, Propacil, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "Immunologic",
      "type": "IMMUNOSUPPRESSIVE AGENTS",
      "genericName": "Sirolimus",
      "brandName": "Rapamune",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic metab mainly by & induces CYP3A4, also CYP3A5 (Drug Metab Disp 35:350,2007. Induces pregnane X receptor."
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Anti-Thymocyte Globulin, Lymphocyte Immune Globulin",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Haemophilus B",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Hepatitis A",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Hepatitis B",
      "brandName": "none",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Influenza",
      "brandName": "none",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Japanese Encephalitis",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Measles, Mumps & Rubella",
      "brandName": "none",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Meningococcal",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Mumps",
      "brandName": "none",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Pneumococcal",
      "brandName": "none",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Polio",
      "brandName": "none",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Rabies",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Typhoid",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Typhoid VI Polysaccharide",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Varicella",
      "brandName": "none",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIMICROBIAL VACCINES",
      "genericName": "Yellow Fever",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIVENINS",
      "genericName": "Antivenin Crotalidae Polyvalent",
      "brandName": "AntiveninPolyvalent",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIVENINS",
      "genericName": "Antivenin Latrodectus Mactans",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIVENINS",
      "genericName": "Antivenin Micrurus Fulvius",
      "brandName": "none",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "ANTIVIRAL MONOCLONAL ANTIBODIES",
      "genericName": "Palivizumab",
      "brandName": "Synagis",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNE GLOBULINS",
      "genericName": "Cytomegalovirus",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "(web.uct.ac.za/depts/porphyria/: Use)"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNE GLOBULINS",
      "genericName": "Hepatitis B",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "(web.uct.ac.za/depts/porphyria/: Use) www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNE GLOBULINS",
      "genericName": "Immune Globulin IV",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "(web.uct.ac.za/depts/porphyria/: Use) www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNE GLOBULINS",
      "genericName": "Rabies",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "(web.uct.ac.za/depts/porphyria/: Use)"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNE GLOBULINS",
      "genericName": "Tetanus",
      "brandName": "none",
      "conclusion": "OK?",
      "references": "(web.uct.ac.za/depts/porphyria/: Use)"
    },
    {
      "class": "IMMUNOLOGIC AGENTS",
      "type": "IMMUNOMODULATORS",
      "genericName": "Thalidomide",
      "brandName": "Thalomid",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Immunologic agents",
      "type": "IMMUNOSUPPRESSIVE AGENTS",
      "genericName": "Azathioprine",
      "brandName": "Imuran",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in animals J Clin Pharmacol 2001;41:113. Safe Not metab by CYPs (www.clinicalpharmacology-ip.com)"
    },
    {
      "class": "Immunologic agents",
      "type": "IMMUNOSUPPRESSIVE AGENTS",
      "genericName": "Cyclosporine",
      "brandName": "Sandimmune",
      "conclusion": "OK?",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in animals J Clin Pharmacol 2001;41:113. Safe Major metab by CYP3A4,3A5. Does not transactivate pregnene X receptor (Biochem Pharmacol 68:1889,2004; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Immunologic agents",
      "type": "IMMUNOSUPPRESSIVE AGENTS",
      "genericName": "Mycophenolate Mofetil",
      "brandName": "CellCept",
      "conclusion": "OK?",
      "references": "J Clin Pharmacol 2001;41:113. Safe ~85% nonmetab by CYP, with minor contribution of CYP3A4/5 (Clin Pharmacokinet 46:13,2007; Therapeutic Drug Monitor 26:600,2004)"
    },
    {
      "class": "Immunologic agents",
      "type": "IMMUNOSUPPRESSIVE AGENTS",
      "genericName": "Tacrolimus",
      "brandName": "Prograf, Protopic",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic J Clin Pharmacol 2001;41:113. Safe Major metab by CYP3A4, 3A5 (Pharmacogenetics & Genomics 19:458,2009)"
    },
    {
      "class": "Immunologic agents",
      "type": "TOXOIDS",
      "genericName": "Diphtheria + Tetanus Toxoids & Acellular Pertussis Adsorbed, Hepatitis B (recombinant) & Inactivated Polioviruis Vaccine Combined",
      "brandName": "Pediatrix",
      "conclusion": "OK!",
      "references": "All component parts of this vaccine are safe individually as well."
    },
    {
      "class": "NARCOTIC ANTAGONISTS",
      "type": "n/a",
      "genericName": "Naloxone",
      "brandName": "Narcan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Opioid derivative metabolised by a series of CYPs, mainly 3A4. Two references: Use www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Acetylcholine",
      "brandName": "Miochol",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Apraclonidine",
      "brandName": "Iopidine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Betaxolol",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Bimatoprost",
      "brandName": "Lumigan",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Brimonidine",
      "brandName": "Alphagan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Cyclopentolate",
      "brandName": "Cyclogyl",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Dapiprazole",
      "brandName": "Rev-Eyes",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Dorzolamide",
      "brandName": "Trusopt",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.drugs.com: excreted primarily as unchanged drug"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Fluorescein",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Homatropine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Latanoprost",
      "brandName": "Xalatan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Naphazoline",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Pilocarpine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Travoprost",
      "brandName": "Travatan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic"
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Trifluridine",
      "brandName": "Viroptic",
      "conclusion": "OK!",
      "references": ""
    },
    {
      "class": "OPHTHALMIC AGENTS (intraocular)",
      "type": "n/a",
      "genericName": "Tropicamide",
      "brandName": "Mydriacyl",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "Psychiatric",
      "type": "ANTI-DEPRESSANT",
      "genericName": "Desvenlafaxine",
      "brandName": "Pristiq",
      "conclusion": "OK?",
      "references": "<5% metab by CYP3A4 (PDR 63:3247,2009). No CyP3A4 inhibition. (CNS Drugs 2012:26:39)"
    },
    {
      "class": "Psychiatric",
      "type": "ANTI-DEPRESSANT",
      "genericName": "Duloxetine",
      "brandName": "Cymbalta",
      "conclusion": "OK?",
      "references": "~97% metab by CYP1A2, 2D6 (Drug Metab Disp 31:1142,2003). No effect on activity of CyP3A4 or 2C9 (CNS Drugs 2012; 26:39) 2 Patient reports:safe. Report of questionable patient: unsafe."
    },
    {
      "class": "Psychiatric",
      "type": "ANTI-DEPRESSANT",
      "genericName": "Mirtazapine",
      "brandName": "Remeron",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. 1/4 not metab, 1/3 metab by CYP2D6, rest by CYP3A4, 1A2. Moderate activation of pregnane X receptor but low prediction of clinical induction (Clin Pharmacogenet 38:461,2000; Cur Drug Metab 7:375,2006). Patient reports: safe"
    },
    {
      "class": "Psychiatric",
      "type": "ANTI-DEPRESSANT",
      "genericName": "Venlafaxine",
      "brandName": "Effexor",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly porphyrinogenic. www.porphyria.uct.ac.za: Use only with extreme caution. Fogelman SM: Neuropsychopharm 1999; 20:480: Major metabolism via CYP2D6 (90%), 2C19 (9%); or also CYP3A4 (CNS Drugs 2012; 26:39). Sinz M: Cur Drug Metab 2006; 7:375: No activation of pregnane X receptor."
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Asenapine",
      "brandName": "Saphris",
      "conclusion": "No info",
      "references": "Metab by CYPs; proportion by CYP3A4 unknown (Drug Metab Disp 39:580, 2011)"
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Bupropion",
      "brandName": "Wellbutrin, Zyban",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Unlikely Porphyrinogenic. USP DI? Drug Info. for the Health Care Pro. - 26th Ed: Metabolized primarily by CYP2B6 (also CNS Drugs 2012; 26:39) & CYP2D6; Moderately transactivates pregnane X receptor but has low probability of inducing CYP3A4 (Curr Drug Metab 9:598,2008; http://medicine.iupui.edu/clinpharm/ddis/)"
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Clozapine",
      "brandName": "Clozaril",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic. Metab. mainly by CYP1A2, to lesser extent by CYP3A & other CYPs. Induces CYP 3A, 2C9. Minimal transactivation of pregnane X receptor (Eur J Pharm Sci 20:451, 2003; Curr Drug Metab 11:516, 2010; Toxicol Lett 82:203, 2011)"
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Dexmedetomidine",
      "brandName": "Precedex",
      "conclusion": "OK?",
      "references": "~14% metab. by CYP2A6, remainder by glucuronidation."
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Iloperidone",
      "brandName": "Fenapt",
      "conclusion": "No info",
      "references": "99% metab, mainly by CYP2D6, less so by CYP3A4 (Curr Drug Metab 11:516, 2010)"
    },
    {
      "class": "Psychiatric",
      "type": "Misc.",
      "genericName": "Olanzapine",
      "brandName": "Zyprexa",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably not porphyrinogenic. www.porphyria_europe.com: Safe. Minor metab. by CYP1A2, 2D6 ?3A4. Moderate activation of pregnane X receptor & low prediction of clinical induction (Basic Clin Pharmacol Toxicol 100:4,2007; Cur Drug Metab 7:375,2006; Curr Drug Metab 11:516,2010)"
    },
    {
      "class": "Psychiatric",
      "type": "Misc.",
      "genericName": "Quetiapine",
      "brandName": "Seroquel",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Metab. mainly by CYP3A4. No evidence for its induction. (http://medicine.iupui.edu/clinpharm/ddis/; Basic Clin Pharmacol Toxicol 100:4,2007) Patient report: safe"
    },
    {
      "class": "Psychiatric",
      "type": "Misc.",
      "genericName": "resperidone",
      "brandName": "Resperdal, etc.",
      "conclusion": "OK?",
      "references": "Major metab via CyP2D6. Weak inhibition of Cyp3A, PXR."
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Risperidone",
      "brandName": "Risperdal",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic. Spina E: Basic Clin Pharmacol Toxicol 2007; 100:4: Substrate mainly of CYP2D6, less of 3A4. Sinz M. Cur Durg Metab 2006; 7:375: No activation of pregnane X rerceptor. Toxicol Lett 203:82, 2011: modest activation of pregnane X receptor (1/5 that of rifampin)."
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Trazodone",
      "brandName": "Desyrel",
      "conclusion": "BAD?",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in animals Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; http://medicine.iupui.edu/clinpharm/ddis/)"
    },
    {
      "class": "Psychiatric",
      "type": "MISC.",
      "genericName": "Ziprasidone",
      "brandName": "Geodon",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic 1/3 metabolized by CYP3A4 (www.rxlist.com; J Clin Psychopharm 23:229,2003)"
    },
    {
      "class": "Psychiatric",
      "type": "PHENOTHIAZINES",
      "genericName": "Chlorpromazine",
      "brandName": "Thorazine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data: Safe JAMA 1965;194:1042. Safe in patients Substrate of CYP3A4. Does not or does moderately transactivate pregnane X receptor. and does transactivate constitutive androgen receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006; Xenobiotica 37:1196,2007; J Pharmacol Exp Therap 320:72, 2007)"
    },
    {
      "class": "Psychiatric",
      "type": "SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Citalopram",
      "brandName": "Celexa",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic. Substrate of CYP3A. web.uct.ac.za/depts/porphyria/: Use with Caution. 1 Patient report: safe. 1 patient report: unsafe"
    },
    {
      "class": "Psychiatric",
      "type": "SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Escitalopram",
      "brandName": "Lexapro",
      "conclusion": "No info",
      "references": "Major metabolism by CYP2C19, CYP3A4; no inhibition of CYP3A4 (CNS Drugs 2012; 26:39)"
    },
    {
      "class": "Psychiatric",
      "type": "SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Fluoxetine",
      "brandName": "Prozac",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in patients Substrate of CYP2C9 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007) Does not induce pregnane X receptor (Toxicol Lett 203:82, 2011) Patient reports: safe"
    },
    {
      "class": "Psychiatric",
      "type": "SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Paroxetine",
      "brandName": "Paxil",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution Does not induce pregnane-X-receptor (Toxicol Lett 203:82, 2011)."
    },
    {
      "class": "Psychiatric",
      "type": "SSELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Fluvoxamine",
      "brandName": "Luvox",
      "conclusion": "OK?",
      "references": "Prob ~65% metab by CYP2D6 + alcohol dehydrogenase (Xenobiotica 37:169,2007). Inhibits CYP3A4."
    },
    {
      "class": "Psychiatric",
      "type": "TRICYCLICS",
      "genericName": "Amitriptyline",
      "brandName": "Elavil",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably unsafe Substrate of many CYPs, including CYP3A4, but does not transactivate pregnane X receptor (http://medicine.iupui.edu/clinpharm/ddis/; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375, 2006) patient reports: safe"
    },
    {
      "class": "Psychiatric",
      "type": "TRICYCLICS",
      "genericName": "Imipramine",
      "brandName": "Tofranil",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably unsafe Metab by CYP2C19, 2D6, 3A4. (http://medicine.iupui.edu/clinpharm/ddis/; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Psychiatric medications",
      "type": "AGENTS FOR CHEMICAL DEPENDENCY",
      "genericName": "Disulfiram",
      "brandName": "Antabuse",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic Eur J Clin Chem Clin Biochem 1997;35:427. Safe in patients Major metabolism by CYP3A4/3A5. Inhibits but probably does not induce CYPs (Alcohol Clin Exp Res 22:1212,1998; Arch Toxicol 82:667,2008)"
    },
    {
      "class": "Psychiatric medications",
      "type": "AGENTS FOR CHEMICAL DEPENDENCY",
      "genericName": "Naltrexone",
      "brandName": "Vivitrol",
      "conclusion": "OK?",
      "references": "No CYP metabolism (PDR 63:988, 2009)"
    },
    {
      "class": "Psychiatric medications",
      "type": "ANTIDEMENTIA AGENTS",
      "genericName": "Donepezil",
      "brandName": "Aricept",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic www.drugs.com: ~80% metab via CYP2D6, 3A4 (www.clinicalpharmacology-ip.com; Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Psychiatric medications",
      "type": "ANTIDEMENTIA AGENTS",
      "genericName": "Memantine",
      "brandName": "Namenda",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.rxlist.com: ca. 50% excreted unchanged; no significant metabolic role for CYPs"
    },
    {
      "class": "Psychiatric medications",
      "type": "MISC.",
      "genericName": "Aripiprazole",
      "brandName": "Abilify",
      "conclusion": "No info",
      "references": "Metab mainly by CYP3A4,2D6 (Curr Drug Metab 9:410,2008)"
    },
    {
      "class": "Psychiatric medications",
      "type": "MISC.",
      "genericName": "Dextroamphetamine",
      "brandName": "Dexedrine",
      "conclusion": "BAD?",
      "references": "Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Psychiatric medications",
      "type": "MISC.",
      "genericName": "Haloperidol",
      "brandName": "Haldol",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic. www.porphyria-europe.com: Safe. web.uct.ac.za/depts/porphyria/: Use. www.uq.edu.au/porphyria/: Probably unsafe. Substrate mainly of 3A4, also 3A5, 3A7. Moderate activation of human pregnane X receptor & low prediction of clinical induction. (Chem Res Toxicol 2006; 19:914; Cur Drug Metab 2006; 7:375)"
    },
    {
      "class": "Psychiatric medications",
      "type": "MISC.",
      "genericName": "Lithium",
      "brandName": "Eskalith, Lithobid",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients"
    },
    {
      "class": "PSYCHIATRIC MEDICATIONS",
      "type": "MISC.",
      "genericName": "Methylphenidate",
      "brandName": "Ritalin",
      "conclusion": "OK?",
      "references": "www.drugs.com: Major metabolic route probably does not involve P450"
    },
    {
      "class": "Psychiatric medications",
      "type": "MISC.",
      "genericName": "Paliperidone",
      "brandName": "Invega",
      "conclusion": "OK?",
      "references": "60% excreted unchanged. Small amt metab by CYP2D6,?other CYPs (Drug Metab Disp 36:769,2008)"
    },
    {
      "class": "PSYCHIATRIC MEDICATIONS",
      "type": "MISC.",
      "genericName": "Phenelzine",
      "brandName": "Nardil",
      "conclusion": "BAD!",
      "references": "web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in animals"
    },
    {
      "class": "PSYCHIATRIC MEDICATIONS",
      "type": "PHENOTHIAZINES",
      "genericName": "Fluphenazine",
      "brandName": "Prolixin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use"
    },
    {
      "class": "PSYCHIATRIC MEDICATIONS",
      "type": "PHENOTHIAZINES",
      "genericName": "Perphenazine",
      "brandName": "Trilafon",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution"
    },
    {
      "class": "Psychiatric medications",
      "type": "PHENOTHIAZINES",
      "genericName": "Prochlorperazine",
      "brandName": "Compazine, Compro, Combid, others",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data: Safe"
    },
    {
      "class": "Psychiatric medications",
      "type": "PHENOTHIAZINES",
      "genericName": "Thioridazine",
      "brandName": "Mellaril",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Caution www.uq.edu.au/porphyria/: Safe in patients Polish J Pharmacol 2001;53:615. Metabolized by CYP2D6;inhibits CYP1A2 and CYP3A2"
    },
    {
      "class": "Psychiatric medications",
      "type": "SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)",
      "genericName": "Sertraline",
      "brandName": "Zoloft",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Substrate of CYP3A4 but minimially transactivates pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006."
    },
    {
      "class": "Psychiatric medications",
      "type": "TRICYCLICS",
      "genericName": "Doxepin",
      "brandName": "Sinequan, Adepin, others",
      "conclusion": "OK?",
      "references": "Medicine (Balt)1992;71:1. Safe Patient report: Safe"
    },
    {
      "class": "Psychiatric medications",
      "type": "TRICYCLICS",
      "genericName": "Nortriptyline",
      "brandName": "Aventyl",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Probably unsafe. Metab by CYP2D6. Does not transactivate pregnane X receptor (http://medicine.iupui.edu/clinpharm/ddis/; Curr Drukg Metab 7:375,2006)"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Albuterol",
      "brandName": "Ventolin, Proventil, others",
      "conclusion": "OK!",
      "references": "PV Tishler MD clinical data, 3 patient reports: Safe https://online.epocrates.com/front_porch/: Metabolized extensively by P450. Does not transactivate pregnane X receptor (Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Budesonide",
      "brandName": "Pulmicort, Rhinocort, Entocort",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic PV Tishler MD clinical data & patient report: Safe Metab by CYP3A"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Fluticasone",
      "brandName": "Flovent",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic PV Tishler MD clinical data & patient reports: Safe Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Formoterol",
      "brandName": "Foradil, Perforomist",
      "conclusion": "OK?",
      "references": "Secondary metab via 4 CYPs (PDR 63:1025,2009), inc. CYP2C9"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Montelukast",
      "brandName": "Singulair",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic Substrate of CYP3A4 & CYP2C9. No inhibition of CYP2C9, 3A4. Moderate transactivation of pregnane X receptor but low prediction of CYP3A4 induction (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375, 2006) Patient report: Safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Zafirlukast",
      "brandName": "Accolate",
      "conclusion": "BAD?",
      "references": "Substrate of CYP2C9. Induces pregnane X receptor. (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Respiratory",
      "type": "ANTIHISTAMINES",
      "genericName": "Cetirizine",
      "brandName": "Zyrtec",
      "conclusion": "OK!",
      "references": "Mainly excreted unchanged. Does not induce CYPs (Cur Med Therap 15:2193,2008; Med Letter 49:97,2007). 1 patient report: safe."
    },
    {
      "class": "Respiratory",
      "type": "ANTIHISTAMINES",
      "genericName": "Chlorpheniramine",
      "brandName": "Chlor-Trimeton, others",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients Metab by CYP2D6, CYP3A4, 2D9 (Pharmacogenetics 1999;9:71; J Pharm Pharmacol 49:257,1997) Patient report: Safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTIHISTAMINES",
      "genericName": "Diphenhydramine",
      "brandName": "Benadryl",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use Patient reports: Safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTIHISTAMINES",
      "genericName": "Fexofenadine",
      "brandName": "Allegra",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic USP DI? Drug Info. for the Health Care Pro. - 26th Ed. (2006): Ca. 1% metabolized by P450, ~5% total. Patient reports: Safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTIHISTAMINES",
      "genericName": "Loratadine",
      "brandName": "Claritin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use with Caution Substrate of CYP3A4, 2C9. Moderate transactivator of pregnane X receptor, but low probability of inducing CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Mertab 7:375,2006) 3 Patient reports: safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTITUSSIVES (Cough Therapies)",
      "genericName": "Benzonatate",
      "brandName": "Tessalon, etc.",
      "conclusion": "OK?",
      "references": "patient report: safe"
    },
    {
      "class": "Respiratory",
      "type": "ANTITUSSIVES (Cough Therapies)",
      "genericName": "Dextromethorphan",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use Metab by CYP3A4."
    },
    {
      "class": "Respiratory",
      "type": "Asthma Treatment",
      "genericName": "Fluticasone",
      "brandName": "Advair",
      "conclusion": "OK?",
      "references": "fluticasone = corticosteroid; salmeterol, brochodilator, metab via CYP3A. Used by inhalation. 1 patient report: safe."
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Aminophylline",
      "brandName": "Many",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Avoid"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Arformoterol",
      "brandName": "Brovana",
      "conclusion": "OK?",
      "references": "Secondary metab via 4 CYPs (PDR 63:2990,2009)"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Beclomethasone (Inhalant)",
      "brandName": "Beclovent, Vanceril, others",
      "conclusion": "OK!",
      "references": "www.uq.edu.au/porphyria/: Safe in patients PV Tishler MD clinical data: Safe"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Cromolyn",
      "brandName": "Intal, others",
      "conclusion": "OK?",
      "references": ""
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Flunisolide (Inhalant)",
      "brandName": "Aerobid, Nasalide, Nasarel",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Ipratropium",
      "brandName": "Atrovent",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic http://www.bidocs.com/renetnt:/Prescribing+ Information/PIs/Atrovent+Nasal+03/ATR03.pdf: Metabolized via hydrolysis patient report: safe"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Salmeterol",
      "brandName": "Serevent",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Terbutaline",
      "brandName": "Brethine",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic Eur. J. Clin. Pharmacol. 1993;45 :483. No metabolism in liver"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIASTHMATIC AND BRONCHODILATOR AGENTS",
      "genericName": "Theophylline",
      "brandName": "Many",
      "conclusion": "BAD?",
      "references": "www.drugs-porphyria.org: Probably Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients Medicine (Balt) 1992;71:1. Safe Substrate of CYP3A4, but does not transactivate pregnane X receptor (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007; Curr Drug Metab 7:375,2006)"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIHISTAMINES",
      "genericName": "Azatadine",
      "brandName": "Optimine, Trinalin, others",
      "conclusion": "No info",
      "references": ""
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "ANTIHISTAMINES",
      "genericName": "Cyproheptadine",
      "brandName": "Periactin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIHISTAMINES",
      "genericName": "Hydroxyzine",
      "brandName": "Atarax, Vistaril",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTIHISTAMINES",
      "genericName": "Levocetirizine",
      "brandName": "Xyzal",
      "conclusion": "OK!",
      "references": "Mainly excreted unchanged. Does not induce CYPs (Curr Med Therap 15:2193, 2008; Med Letter 49:97,2007)"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "ANTIHISTAMINES",
      "genericName": "Promethazine",
      "brandName": "Phenergan",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Probably unsafe Curr Drug Metab 2003;4:105. Metabolized by CYP2D6"
    },
    {
      "class": "Respiratory agents",
      "type": "ANTITUSSIVES (Cough Therapies)",
      "genericName": "Hydrocodone",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007. Substrate of CYP3A4 Patient reports: Safe"
    },
    {
      "class": "Respiratory agents",
      "type": "EXPECTORANTS",
      "genericName": "Guaifenesin",
      "brandName": "Robitussin",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution PV Tishler MD clinical data & patient report: Safe"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "MUCOLYTICS",
      "genericName": "Acetylcysteine",
      "brandName": "Mucomyst",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Not Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use PV Tishler MD clinical data: Safe Eur J Clin Chem Clin Biochem 1997;35:427. Safe"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "NASAL AGENTS - SYSTEMIC AND TOPICAL",
      "genericName": "Oxymetazoline",
      "brandName": "Afrin",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic www.uq.edu.au/porphyria/: Unsafe in patients"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "NASAL AGENTS - SYSTEMIC AND TOPICAL",
      "genericName": "Phenylephrine",
      "brandName": "Many",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org: Probably Not Porphyrinogenic"
    },
    {
      "class": "RESPIRATORY AGENTS",
      "type": "NASAL AGENTS - SYSTEMIC AND TOPICAL",
      "genericName": "Pseudoephedrine",
      "brandName": "Sudafed",
      "conclusion": "OK!",
      "references": "www.porphyria-europe.com: Safe web.uct.ac.za/depts/porphyria/: Use www.uq.edu.au/porphyria/: Safe in patients Patient reports: Safe"
    },
    {
      "class": "URINARY TRACT",
      "type": "ANALGESICS",
      "genericName": "Phenazopyridine",
      "brandName": "Pyridium",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "URINARY TRACT",
      "type": "ANTISPASMODICS",
      "genericName": "Bethanechol",
      "brandName": "Urecholine",
      "conclusion": "NO INFO",
      "references": ""
    },
    {
      "class": "Urinary tract",
      "type": "ANTISPASMODICS",
      "genericName": "Darifenacin",
      "brandName": "Enablex",
      "conclusion": "BAD?",
      "references": "Significantly metab by CYP3A4, 2D6. No evidence of CYP induction (Clin Pharmacokinet 45:325,2006)"
    },
    {
      "class": "Urinary tract",
      "type": "ANTISPASMODICS",
      "genericName": "Oxybutynin",
      "brandName": "Oxytrol, Ditropan",
      "conclusion": "BAD!",
      "references": "www.drugs-porphyria.org: Possibly Porphyrinogenic web.uct.ac.za/depts/porphyria/: Use with Extreme Caution www.drugs.com: Metabolized primarily in liver by CYP3A4 Substrate of CYP3A4 (Williams DA. Drug metabolism. In: Foye's Principles of Medicinal Chemistry, ed. Lemke T and Williams DA. Baltimore, Williams & Wilkins, 6th ed., 2007)"
    },
    {
      "class": "Urinary tract",
      "type": "ANTISPASMODICS",
      "genericName": "Solifenacin",
      "brandName": "Vesicare",
      "conclusion": "OK?",
      "references": "Metab primarily by CYP3A4. No evidence of any CYP induction (Br J Clin Pharmacol 59:647,2004)"
    },
    {
      "class": "Urinary tract",
      "type": "ANTISPASMODICS",
      "genericName": "Tolterodine",
      "brandName": "Detrol",
      "conclusion": "OK?",
      "references": "www.drugs-porphyria.org: Safe in one patient, but possibly porphyrinogenic. Metab by CYP2D6,3A4; CYP3A4 may be increased in CYP2D6 poor metabolizers (Drug Metab Disp 26:289,1998) Patient report to Peter Tishler, MD - safe"
    },
    {
      "class": "Urinary tract",
      "type": "PROSTATIC HYPERTROPHY",
      "genericName": "Dutasteride",
      "brandName": "Avodart",
      "conclusion": "BAD?",
      "references": "Extensively metab by CYP3A4,3A5 (PDR 63:1359,2009). 2 patient reports: unsafe"
    },
    {
      "class": "Urinary tract",
      "type": "PROSTATIC HYPERTROPHY",
      "genericName": "Tamsulosin",
      "brandName": "Flomax",
      "conclusion": "BAD?",
      "references": "Extensively metab by CYP3A4,2D6 (Xenobiotica 28:909, 1998; PDR 63:848,2009)."
    },
    {
      "class": "Urinary tract",
      "type": "PROSTATIC HYPERTROPHY (also Baldness)",
      "genericName": "Finasteride",
      "brandName": "Proscar, Propecia",
      "conclusion": "OK!",
      "references": "www.drugs-porphyria.org:Possibly porphyrinogenic. www.porphyria.uct.ac.za: Use only with extreme caution. Metab mainly by CYP3A4. Little activation of pregnane X receptor (Huskey SW: Drug Metab Disp 1996; 24:695; Sinz M. Cur Drug Metab 2006; 7:375)"
    },
    {
      "class": "Anti-infectives",
      "type": "ANTIRETROVIRALS",
      "genericName": "nirmatrelvir tablets and ritonavir tablets",
      "brandName": "PAXLOVID",
      "conclusion": "BAD!",
      "references": "PAXLOVID ( nirmatrelvir tablets; ritonavir tablets has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. see comments on ritonavir in the drug database."
    }
  ],
  "metadata": {
    "source": "https://www.porphyriafoundation.org/drugsafety_listall.cfm",
    "totalRecords": 720,
    "lastUpdated": "2025-10-06",
    "description": "Base de datos oficial de seguridad de medicamentos para pacientes con Porfiria de la Porphyria Foundation"
  }
}